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Abstract 
Despite the known benefits of performing aerobic and resistance exercise independently, 
the metabolic effects of performing aerobic and resistance exercise in succession, remain 
unclear. Several studies suggest that the alteration of exercise sequence may influence 
carbohydrate and lipid oxidation and energy expenditure during exercise and in recovery. High 
intensity resistance exercise performed prior to a bout of aerobic exercise has been shown to 
augment fat oxidation during the subsequent bout of aerobic exercise. Changes in hormone and 
metabolite concentrations from prior resistance exercise could potentially influence substrate 
selection and energy expenditure in a subsequent bout of aerobic exercise. However, an exercise 
session whereby aerobic exercise is followed by a bout of resistance exercise has yet to be 
evaluated to determine the metabolic effects (specifically, the differences in substrate selection 
for energy provision) when exercise sequence is altered. It was hypothesized that when 
resistance exercise was performed prior to a bout of aerobic exercise, sympathetic nervous 
system activity would be elevated, leading to an increase in non-esterified fatty acid (NEFA) and 
glycerol concentrations and resultant increase in lipid oxidation during the aerobic portion of the 
exercise compared to the opposite sequence.  It was also hypothesized that during recovery there 
would be an increased reliance on fat oxidation for energy provision with a resistance-aerobic 
exercise sequence compared to an aerobic-resistance exercise sequence. Additionally, the 
differences in metabolite concentrations and respiratory parameters between two identical bouts 
of aerobic exercise performed on separate days (~1 week apart) were measured and it was 
hypothesized that day-to-day variability would be non-significant (p>0.05). Plasma glucose, 
lactate, NEFA, glycerol, insulin, C-peptide, glucagon, epinephrine and norepinephrine 
concentrations in addition to oxygen consumption (VO2) and respiratory exchange ratio (RER) 
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were measured in nine healthy, recreationally active males that participated in 3 different, 
randomized exercise trials (Trial A: aerobic exercise; Trial AR: aerobic exercise followed by a 
bout of resistance exercise; Trial RA: resistance exercise followed by an aerobic exercise bout). 
The aerobic exercise bout was performed at 60% VO2 max for 30 min while the resistance 
exercise bout consisted of 5 exercises (overhead squat, chest press, triceps extension, shoulder 
press, and dead-lift) performed for 3 sets of 8 repetitions at 70% 1-RM.  Contrary to the primary 
hypothesis, NEFA concentrations and lipid oxidation rates were similar for the aerobic exercise 
bout of both the AR and RA trials. During recovery, lipid oxidation was elevated immediately 
post-exercise in the RA trial compared to the AR trial, however there were no differences 
between trials by 15 min post-exercise. Furthermore, only epinephrine, and not norepinephrine, 
concentrations were significantly higher after aerobic exercise in the RA trial compared to the 
AR trial.  VO2 and energy expenditure values were similar for the duration of the 30 min 
recovery. These results suggest that while exercise sequence may influence carbohydrate and 
lipid oxidation immediately post exercise, substrate selection and utilization are similar during 
aerobic exercise bouts irrespective of the sequence in which aerobic and resistance exercise are 
performed. Thus, when resistance exercise is performed prior to aerobic exercise, compared to 
the opposite sequence, overall energy provision is not altered at the volume and intensity of 
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1.0  Introduction to the Regulation of Substrate Metabolism in Whole Body and in 
Skeletal Muscle 
 
1.1 The Importance of Regulation of Substrate Metabolism in Mixed Aerobic-Resistance 
Exercise: An Overview 
  It is well established that exercise stimulates increased carbohydrate and lipid oxidation 
in skeletal muscle during exercise and in post-exercise recovery (DeFronzo et al, 1981; Melby et 
al, 1993; Romijn et al, 1993b; Romijn et al, 1995; Petitt et al, 2003; van Loon et al, 2003; 
Durham et al, 2004; Dreyer et al, 2008; Singhal et al, 2009). While these studies investigated 
substrate utilization in aerobic and resistance exercise independently, there is increasing interest 
in evaluating substrate metabolism during mixed aerobic-resistance exercise sessions (Goto et al, 
2007; Kang et al, 2009). Investigating combined aerobic-resistance exercise sessions will 
advance our understanding of substrate metabolism and energy expenditure, and may be applied 
to weight loss and maintenance programs. Goto et al (2007) found that resistance exercise 
administered prior to an aerobic bout of exercise resulted in a greater increase in lipolysis during 
the subsequent aerobic activity compared to aerobic activity alone. Similarly, participants in a 
study by Kang et al (2009) completed resistance exercise of varying intensities (i.e. high versus 
low intensities) prior to engaging in a bout of aerobic exercise. The results of this study 
demonstrated that a preceding bout of high intensity—but not low intensity— resistance exercise 
augmented lipid oxidation during a subsequent bout of aerobic exercise. However, the opposite 
exercise sequence (i.e. aerobic followed by resistance exercise) has yet to be evaluated to 
determine the metabolic effects of exercise sequence on substrate selection for energy provision. 
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Changes in hormone and metabolite concentrations from prior exercise (e.g. increased 
catecholamines and decreased glucose resulting from a bout of resistance exercise) could 
potentially influence substrate selection and energy expenditure in a subsequent bout of exercise 
(Goto et al, 2007). When aerobic and resistance exercise are performed in succession, a more 
thorough understanding is needed of: 1) the potential differences in carbohydrate and lipid 
oxidation during and post-exercise when the sequence of aerobic and resistance exercise is 
altered, and 2) the potential mechanisms for determining the type and proportion of substrate 
involved in energy provision during different sequences of exercise. The knowledge gained from 
this area of research can be applied to design exercise programs that promote weight loss and 
weight maintenance in healthy, and possibly disease populations.  
 
1.2 Regulation of Whole Body Substrate Metabolism: General Effects of Rest, Exercise and 
Dietary Influences   
Insulin, glucagon and catecholamines (i.e. epinephrine and norepinephrine) have 
important roles in oxidizing substrates for energy provision (Bitensky et al, 1968; DeFronzo et 
al, 1981; Jiang and Zhang, 2003). To maintain energy provision (i.e. during exercise or following 
an overnight fast), low plasma insulin concentrations result in a reduced inhibition of 
intracellular lipases, which increase adipose tissue lipolysis and non-esterified fatty acid (NEFA) 
mobilization into systemic circulation (Goto et al, 2007b). Increased NEFA mobilization 
enhances NEFA availability for skeletal muscle uptake, and subsequent oxidation.  Skeletal 
muscle and other lean tissues, not only rely on fatty acids for energy but also on plasma glucose 
as an energy substrate (Johnson et al, 2010). Thus, to maintain glucose homeostasis during 
periods of high-energy demands and/or fasting, liver glycogenolysis and gluconeogenesis 
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produce glucose, which is released into circulation (Wahren et al, 1971). During a fasted state, 
healthy individuals exhibit low insulin concentrations, and glucagon primarily regulates plasma 
glucose production through gluconeogenesis (Exton et al, 1967; Lavoie et al, 1997). High 
glucagon concentrations signal an increase in energy demand and stimulate gluconeogenesis and 
glycogenolysis in liver (Exton et al, 1968; Petersen et al, 2004).  In skeletal muscle, epinephrine 
stimulation enhances intramuscular glycogen utilization, glycolysis and carbohydrate oxidation 
rates (Febbraio et al, 1998). However, during fasting conditions, epinephrine circulates in low 
concentrations and may not be a primary contributor to glucose homeostasis at rest (Näveri et al, 
1985).  
In contrast, substrate selection is altered with exercise compared to resting and fasting 
conditions. ATP demands are elevated and are accompanied by increased catecholamine and 
glucagon concentrations, as well as reduced insulin concentrations (Gyntelberg et al, 1977, 
Näveri et al, 1985; Goto et al, 2007b). These signals ultimately result in greater glucose 
production and NEFA mobilization to match these energy demands. Greater substrate 
availability primarily occurs through increased lipolysis in adipose tissue, glycogenolysis in 
skeletal muscle and gluconeogenesis in the liver (Exton et al, 1972b). During low intensity 
exercise, when insulin levels are reduced, plasma NEFAs are the primary energy substrate 
oxidized by skeletal muscle (Romijn et al, 1993b). However, the greater rates of lipid oxidation 
occur during moderate intensity exercise (~50-75% VO2max) (Romijn et al, 1993b). Despite the 
high reliance on lipid metabolism for energy provision, glucose uptake is still elevated for the 
duration of an acute bout of moderate intensity exercise. Of note, the higher the intensity of 
exercise, the greater the inhibition of NEFA mobilization (Romijn et al, 1993; Romijn et al, 
1995), and consequently, carbohydrate oxidation becomes the dominant substrate for ATP 
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production (van Loon et al, 2001). Epinephrine is also elevated in direct proportion to exercise 
intensity, which would inhibit NEFA mobilization and promote carbohydrate oxidation at high 
intensity exercise. Glucagon would also stimulate liver glycogenolysis and gluconeogenesis as 
well as skeletal muscle glycogenolysis and glycolysis during high intensity exercise (Petersen et 
al, 2004; Perry et al, 2008). 
Food intake at rest can also influence substrate oxidation. A high fat meal at rest will 
increase circulating NEFAs as well as a reliance on NEFAs as energy substrate (Griffiths et al, 
1994). The presence of insulin following a high fat meal will enhance translocation of CD 36, a 
fatty acid transporter, to the skeletal muscle membrane for fatty acid uptake (Schwenk et al, 
2010). Concomitantly, glucagon concentration is reduced, attenuating glycogenolysis in the liver 
and skeletal muscle, as well as liver gluconeogenesis (Jiang and Zhang, 2003). In adipose tissue, 
decreased glucagon and increased insulin concentrations reduce NEFA mobilization and promote 
triacylglycerol (TAG) storage.   
Conversely, a high carbohydrate meal will increase plasma glucose concentrations, 
stimulating glucose uptake and providing more substrate for skeletal muscle glycolysis or for 
glycogen storage (Acheson et al, 1988). Increased concentrations of plasma glucose lead to the 
release of insulin from the pancreas and subsequent binding of insulin to receptors on skeletal 
muscle, liver and adipose tissue. Insulin signaling promotes glucose uptake through increased 
translocation of GLUT 4 to the plasma membrane (James et al, 1994); this ultimately promotes 
increased glycogen synthesis in the liver and skeletal muscle. Contraction-induced translocation 
of GLUT4 and CD36 to the plasma membrane (Schwenk et al, 2010) will promote carbohydrate 
and lipid uptake for oxidation when the availability of these respective substrates is elevated 
during exercise. However, during an acute bout of steady-state exercise, Watt et al (2002) found 
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that carbohydrate ingestion (1gram/kg body weight) 75 min prior to aerobic exercise did not 
affect oxidative metabolism. Thus, a meal ingested prior to an overnight fast will not likely 
influence substrate oxidation during exercise. 
 
1.3 Regulation of Substrate Metabolism in Skeletal Muscle during Exercise 
ATP homeostasis is maintained through precise coordination of energy-regulating 
hormones, especially insulin, glucagon and catecholamines. Additional signals regulate pathways 
for carbohydrate and lipid metabolism in muscle including increased cellular AMP: ATP ratio, 
low plasma glucose and increased intracellular calcium concentrations, which predominantly 
occur during exercise. Rises in intramuscular calcium concentrations stimulate the AMPK 
pathway (Abbott et al, 2009), which is part of a signaling cascade that increases the translocation 
of GLUT 4 to the plasma membrane and ultimately increases glucose availability within skeletal 
muscle (Kurth-Kraczek et al, 1999; Ojuka et al, 2002). GLUT 4 is the main glucose transporter 
isoform for skeletal muscle glucose uptake (Gaster et al, 2000); it is regulated by muscle 
contraction (i.e. increases in calcium concentration which stimulate AMPK) as well as by plasma 
insulin. Binding of insulin to the insulin receptor (IR) induces autophosphorylation of the 
receptor as well as phosphorylation of the insulin receptor substrate (IRS-1) (Lizcano and Alessi, 
2002; Figure 1). Activated IRS-1 subsequently associates with other enzymes in the insulin-
signaling cascade to ultimately activate Akt (a serine kinase; also referred to as Protein Kinase 
B), which then increases GLUT 4 translocation to the plasma membrane (Lizcano and Alessi, 
2002; Figure 1). However, insulin concentrations are normally low during exercise, and thus, 
GLUT4 translocation is primarily stimulated by contraction during exercise (Kennedy et al, 
1999).  
 6 
Once glucose is inside the cell, hexokinase transfers an inorganic phosphate from ATP to 
glucose, forming glucose-6-phosphate (G6P). This reaction is irreversible, ensuring that once 
glucose is taken up via GLUT 4, it becomes trapped within the skeletal muscle thus maintaining 
a high concentration gradient for glucose to continue entering the cell. Hexokinase production is 
up-regulated when the AMP:ATP ratio rises during moderate-high intensity exercise (>50-
60%VO2max), signaling a need for increased energy provision (Ojuka et al, 2000).  
 There are additional key points of regulation in glycolysis, including 
phosphofructokinase (PFK) and pyruvate kinase (PK), that are sensitive to energy changes (i.e. 
AMP: ATP ratio) and/or hormones such as epinephrine and glucagon. Similar to hexokinase, a 
higher AMP: ATP ratio (Stanley and Connett, 1991) and higher plasma glucagon concentrations 
activate PFK, increasing glycolytic rate. Epinephrine also indirectly increases PFK activity 
through AMPK signaling (Michiels, 2004). Therefore, with high intensity exercise, plasma 
glucagon and epinephrine concentrations rise to a greater extent and further increase PFK 
activity to favor carbohydrate oxidation compared to lower intensity exercise. PK converts 
phosphoenolpyruvate formed during glycolysis to pyruvate (Figure 1). This enzyme is also 
energy-sensitive such that during exercise when AMP levels rise and ATP concentrations drop, 
PK activity is elevated (Smart and Pritchard, 1982). 
Once pyruvate is formed, it has two fates: it can enter the tricarboxylic acid cycle (TCA 
cycle) via pyruvate dehydrogenase (PDH) or be converted to lactate by lactate dehydrogenase. 
At rest and during low-to-moderate intensity exercise, pyruvate is predominantly regulated by 
PDH (Stephens et al, 2010). PDH irreversibly converts pyruvate into acetyl-CoA, which can be 
oxidized in the TCA cycle (Figure 1). The PDH complex is primarily regulated by 2 enzymes: 
PDH phosphatase, which promotes the conversion of the PDH complex to its active form 
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(PDHa) and PDH kinase, which converts PDH to its inactive form (PDHb). At rest, the PDH 
complex is found as PDHb (Kiilerich et al, 2008). With the onset of exercise, Ca
2+
 and a rise in 
pyruvate activate PDH phosphatase to convert PDHb to PDHa, increasing carbohydrate 
oxidation. Insulin similarly increases expression of PDH phosphatase (Wang et al, 2009); with 
an increase in PDH activity, glucose oxidation is enhanced.   
Acetyl-CoA, the end product of the PDH reaction also functions as an allosteric inhibitor 
of PDH (Exton, 1972). Acetyl-CoA can be derived from PDHa as well as through beta-oxidation 
of fatty acids. Therefore, in situations where NEFA concentration is increased (i.e. in a fasted 
state or low-moderate intensity and/or prolonged exercise), a rise in acetyl-CoA inhibits the 
conversion of pyruvate to acetyl-CoA, reducing the rate of glycogenolysis and glycolysis 
Overall, there is a decline in the contribution of carbohydrate oxidation and a concomitant 
increase in lipid oxidation for the production of ATP (Kiilerich et al, 2010). PDH activity, and 
thus carbohydrate oxidation, is thought to be additionally attenuated since there is increased 
expression of pyruvate dehydrogenase kinase 4 (PDK4), which would imply increased PDK4 
activity to phosphorylate PDHa to PDHb (Ehrenborg and Kelly, 2009) (Figure 1). PDK4 is 
therefore another crucial enzyme, secondary to PDH, which regulates the transition from 
carbohydrate to lipid metabolism (Krämer et al, 2007). PDK4 activity is increased by higher 
ratios of ATP: ADP and NAD: NADH, and is inversely correlated with increased exercise 
intensity.   
 The AMPK signaling pathway is also known to promote beta-oxidation indirectly 
through attenuation of lipid synthesis (Brusq et al, 2006). Stimulation of the AMPK pathway 
phosphorylates acetyl-CoA carboxylase (ACC) (Krämer et al, 2007), reducing the conversion of 
acetyl-CoA to malonyl-CoA and ultimately limiting the amount of substrate available for TAG 
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synthesis (Krämer et al, 2007). Since malonyl-CoA is also an inhibitor of carnitine palmitoyl 
transferase 1 (CPT1) (McGarry and Foster, 1980), a reduction of malonyl-CoA removes 
inhibition on CPT1, allowing the enzyme to transfer NEFAs into the mitochondria for beta-
oxidation (Ehrenborg and Kelly, 2009; Sugden et al, 2010), increasing overall skeletal muscle 
lipid oxidation.  
AMPK, which is activated by a rise in AMP, also indirectly activates PCG1-alpha, 
allowing PCG1-alpha to co-activate PPAR-delta (Finck and Kelly, 2006; Ehrenborg and Krook, 
2009), the primary isoform regulating lipid oxidation in response to fasting and exercise 
conditions in skeletal muscle (Krämer et al, 2007; Sugden et al, 2010). Increases in PPAR-delta 
have been associated with increased oxidative enzymes (Wang et al 2004), suggesting that beta-
oxidation would be elevated when PPAR-delta is increased. While there are other fatty acid 
transporters, such as fatty acid binding protein (FABP), CD 36 appears to be the primary fatty 














Figure 1. Schematic of a Skeletal Muscle Cell: Regulation of Glucose and Lipid Oxidation 
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2.0 Substrate Metabolism under Different Exercise Conditions 
There are several points of regulation in glycolysis and oxidative metabolism in skeletal 
muscle. While the majority of work has focused on aerobic exercise metabolism, there is little 
work to understand the effects of resistance exercise on energy-producing pathways and 
substrate utilization. Although there is even less work that has investigated combined aerobic and 
resistance exercise, it is important to understand the potential effects on substrate oxidation and 
energy expenditure when the sequence in which aerobic and resistance exercise bouts are 
performed, is altered.  
 
2.1  Aerobic Exercise and Substrate Metabolism 
With the onset of muscle contraction at the initiation of aerobic exercise, there is a rise in 
epinephrine, intramuscular calcium concentrations and increased production of AMP and ADP 
through ATP utilization (Kahn et al, 2005; Goto et al, 2007b; Lee-Young et al, 2009). 
Epinephrine and calcium have a stimulating effect on glycogen breakdown. At low intensities, 
the influx of Ca
2+
 also activates several key enzymes (eg. hexokinase and PDH phosphatase) 
(Koval et al, 1998; Mourtzakis et al, 2006) that increase pyruvate production and potentially 
carbohydrate oxidation.  
Carbohydrates, from muscle glycogen and plasma glucose, contribute the majority of 
energy provision throughout an entire bout of high intensity aerobic exercise. Romijn et al 
(2000) compared carbohydrate and lipid oxidation rates in endurance trained women and found 
that while lipid oxidation was reduced from 43.1 ± 3.5 µmol/kg/min at 65% VO2max to 30.1 ± 3.6 
µmol/kg/min at 85% VO2max, the rate of carbohydrate oxidation increased from 106.5 ± 11.5 
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µmol/kg/min at 65% VO2max to 232.1 ± 15.1 µmol/kg/min at 85% VO2max. Despite increased 
epinephrine and norepinephrine concentrations with increasing exercise intensities, TAG 
oxidation remains stimulated in muscle and adipose tissue (Hagström-Toft et al, 1998; Quish et 
al, 2005), but relative carbohydrate contribution to total energy provision is greater than that of 
fatty acids. AMPK activity is increased with more frequent muscle contraction (from working at 
higher exercise intensities where ATP utilization and Ca
2+
 concentration are increased) (Raney 
and Turcotte, 2006). Activation of the AMPK pathway increases the amount of GLUT4 
translocated to the plasma membrane (Schwenk et al, 2010), which facilitates glucose uptake and 
ultimately carbohydrate oxidation. In fact, skeletal muscle glucose uptake increased 
approximately ~10-fold compared to rest in a 1-legged knee extensor incremental exercise study 
(Mourtzakis et al, 2008). Intramuscular glycogen stores (Romijn et al, 1993b; Romijn et al, 
1995) also contribute to glucose availability for energy provision. In sync with increased glucose 
uptake, higher glycolytic enzyme activity (i.e. hexokinase, PFK1 and PK) is also stimulated by 
rises in AMP: ATP ratio, enhancing glucose oxidation at higher intensities of aerobic exercise 
compared to lower intensities (Romijn et al, 1993b; Lee-Young et al, 2009).     
Carbohydrate oxidation contributes most appreciably to energy provision only at the 
initiation of low to moderate intensity exercise (Mourtzakis et al, 2006). Romijn et al (1993b) 
found that plasma NEFAs are the primary energy substrate oxidized by muscle during low (25% 
VO2 max) and moderate intensity (65%VO2max) exercise. Lipid oxidation is favored in other acute 
exercise studies of moderate-intensity where catecholamine concentrations are elevated in 
combination with lower plasma insulin concentrations (Savard et al, 1987; Stich et al, 2000; 
Stallknecht et al, 2001; Mourtzakis et al, 2006). Ca
2+
 released during muscle contraction 
activates the AMPK pathway, which increases ACC inhibition and ultimately reduces malonyl-
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CoA production (Brusq et al, 2006). With reduced production of malonyl-CoA, a CPT1 inhibitor 
(McGarry and Foster, 1980), NEFAs can enter the mitochondria for beta-oxidation and thus 
support energy provision.   
 During a moderate intensity exercise bout that lasts more than 30 minutes, there is a shift 
from carbohydrate to lipid oxidation (Romijn et al, 1993b). Goto et al (2007b) found that cycling 
at 60% VO2max for two 30-min bouts resulted in a significant decrease in plasma glucose within 
the first 30 minutes of exercise, which continued to decline for the duration of the exercise. Since 
the decline in glucose was observed within the first 30 min, it is likely that pyruvate production 
was reduced, as a result of decreased AMP and ADP concentrations, which would reduce PDH 
activity and promote acetyl-CoA production via beta-oxidation.   
Increased beta-oxidation increases acetyl-CoA concentrations, providing energy substrate 
for the TCA cycle as well as covalently reducing PDH activity and ultimately reducing glucose 
oxidation (Stephens et al, 2010). Elevated NEFA and glycerol concentrations were evidenced by 
Goto et al (2007b) during moderate intensity exercise, which implied that lipolysis was elevated 
to meet the energy demand of the exercising muscles. NEFA uptake would likely be enhanced 
with AMPK-induced translocation of CD36 to the plasma membrane. AMPK activation occurs 
during moderate intensity exercise when signals such as plasma insulin concentration are 
reduced and intracellular Ca
2+
 concentrations are elevated compared to rest or during low 
intensity exercise (Raney and Turcotte, 2006). AMPK inhibits ACC activity leading to a 
reduction in malonyl-CoA production and removal of the inhibition on CPT1 (Brusq et al, 2006). 
With CPT1 activated, fatty-acyl CoA can enter the mitochondria for beta-oxidation. While these 
changes occur during an acute bout of moderate intensity exercise, post-exercise substrate 
selection and oxidation still require further investigation.  
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2.2 Resistance Exercise and Substrate Metabolism 
Resistance exercise is generally performed at a moderate to high intensity (70% 1RM to 
100% 10 RM) (Melby et al, 1993; Petitt et al, 2003; Ormsbee et al, 2007; Singhal et al, 2009) 
and thus relies on the high-energy phosphate system and carbohydrate metabolism (i.e. 
intramuscular glycogen stores) for energy provision instead of fatty acid oxidation (Robergs et 
al, 1991; Roy and Tarnopolsky, 1998; Dreyer et al, 2008). Durham et al (2004) were the first to 
report that muscle glucose uptake was elevated 5-fold from pre-exercise rates when subjects 
performed 45 minutes of lower body resistance exercise at 70-80% 1RM (the protocol included 8 
sets of 10 repetitions at 70% 1RM followed by 8 sets of 8 repetitions at 80% 1RM). Resistance 
exercise has also been confirmed as a potent stimulator of glucose uptake both during and after 
exercise (Biolo et al, 1999; Dreyer et al, 2008). One potential mechanism for augmented glucose 
uptake in resistance exercise is a threefold increase in blood flow, which enhances glucose 
extraction in the muscle (Durham et al, 2004).  
In addition to muscle contraction, insulin concentrations rise slightly during resistance 
exercise (Dreyer et al, 2008), increasing translocation of GLUT 4 to the sarcolemma for greater 
glucose uptake during moderate-to-high intensity resistance exercise. Generally, the pathways 
that are stimulated at this intensity are similar to those activated during high intensity aerobic 
exercise. The AMPK pathway is activated as the AMP: ATP ratio increases; sequentially, PFK is 
phosphorylated in skeletal muscle resulting in glycolysis. The concomitant rise in catecholamine 
concentrations that also occurs with resistance exercise stimulates the muscular and extra-
muscular tissues to contribute substrate for energy provision. In skeletal muscle, the rise in 
epinephrine along with elevated Ca
2+
 concentrations, activate glycogenolysis. High AMP 
concentrations from ATP utilization increase the rate of glycolytic enzymes (ex. hexokinase, 
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PFK1 and PK), which maintain a steady production of pyruvate. High epinephrine 
concentrations also increase cAMP concentrations within the liver (Cherrington and Exton, 
1976) and result in increased rates of gluconeogenesis; glucose is released into circulation for 
delivery to exercising muscles and ultimately, for skeletal muscle glycolysis. Other tissues, such 
as adipose tissue, also contribute to energy provision during resistance exercise, albeit to a 
relatively smaller extent (Ormsbee et al, 2007). Ormsbee et al (2007) measured increased rates of 
lipolysis in adipose tissue during low-moderate intensity resistance exercise. This increase in 
NEFA availability would likely be followed with an increase in fatty acid uptake by skeletal 
muscle via CD36 for beta-oxidation.  
 
2.3 Substrate Metabolism with Altered Aerobic and Resistance Exercise Sequence in a Single 
Exercise Session  
Moderate intensity aerobic and resistance exercise independently promote increased 
skeletal muscle glucose uptake and rely on intramuscular glycogen stores (with relatively 
moderate contributions from lipid oxidation) for energy provision (Wahren et al, 1971; 
DeFronzo et al, 1981; Romijn et al, 1993b; Romijn et al, 1995; Roy and Tarnopolsky, 1998). 
From a practical perspective, resistance and aerobic exercise are prescribed to individuals to reap 
the benefits of both strength and cardiovascular training. These two exercises are either 
performed within the same exercise session or on separate days. It has been shown that the 
metabolic effects of resistance exercise persist for up to 15 hours post exercise (Melby et al, 
1993; Petitt et al, 2003; Singhal et al, 2009) and for 24 hours after an acute bout of aerobic 
exercise (Magkos et al, 2007). However, there is limited work that examines the metabolic 
effects of performing resistance and aerobic exercise within the same session and whether there 
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are different metabolic effects based on the sequence in which these exercises are performed. 
When resistance exercise is performed immediately prior to aerobic exercise, elevated 
epinephrine concentrations and circulating NEFAs are documented immediately after the 
cessation of the resistance exercise (Goto et al, 2007). This would increase NEFA availability as 
a substrate for energy provision at the onset of aerobic exercise.  
As such, lipid oxidation is augmented during the subsequent aerobic bout (Goto et al, 
2007; Kang et al, 2009).  Elevated catecholamine concentrations immediately following the 
resistance exercise (prior to aerobic exercise) are associated with increased circulating NEFAs 
(Goto et al, 2007); this is likely attributed to increased mobilization of NEFAs from adipose 
tissue into whole-body circulation. Thus, NEFA availability and/or uptake would likely be 
enhanced at the onset of aerobic exercise following a bout of resistance (Goto et al, 2007) or 
aerobic exercise (Goto et al, 2007b) compared to performing aerobic exercise without any 
preceding exercise (Goto et al, 2007). During resistance exercise, plasma insulin is elevated 
(Dreyer et al 2008), which would potentially stimulate translocation of CD36 to facilitate NEFA 
uptake into skeletal muscle (Schwenk et al 2010). With the increased availability of NEFA in 
muscle, more substrate would be expected to be available for CPT1 to transport into the 
mitochondria for beta-oxidation.  
This elevation in beta-oxidation following resistance exercise supports increased lipid 
oxidation at the baseline of a subsequent bout of moderate intensity aerobic exercise. Continuous 
muscle contraction during this subsequent bout of aerobic exercise would maintain a heightened 
intracellular calcium concentration, further enabling the AMPK pathway to indirectly remove the 
inhibition of ACC on CPT1, ultimately maintaining lipid oxidation. Increased acetyl-CoA 
attributed to a rise in NEFA availability inhibits PDH activity to reduce carbohydrate 
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contribution to the TCA cycle, and ultimately, carbohydrate oxidation would be reduced in 
skeletal muscle (Stephens et al, 2010). Therefore, it is necessary to evaluate the changes in blood 
metabolites and energy-related parameters that occur when a bout of resistance exercise is 
performed prior to an aerobic exercise bout. The observation of alterations in substrate selection 
and utilization with alternate exercise sequences will provide the foundation for investigating 
mechanisms associated with these changes in carbohydrate and lipid metabolism. It is evident 
that fat oxidation is enhanced when resistance exercise is followed by aerobic exercise; however, 
the mechanisms for enhanced lipid oxidation remain unclear.  
The opposite sequence of aerobic exercise preceding a resistance exercise bout has not 
been assessed to make comparisons with the alternate exercise sequence (resistance followed by 
aerobic exercise). With moderate intensity aerobic exercise lasting at least 30 min, NEFA 
mobilization occurs in concert with elevated epinephrine and reduced plasma insulin 
concentrations (Goto et al, 2007b). Overall, less carbohydrate is oxidized during aerobic exercise 
compared to resistance exercise. Thus, at the onset of resistance exercise immediately following 
an aerobic exercise bout, NEFA uptake via CD 36 translocation would likely be reduced due to 
reduced plasma insulin concentrations, as compared to the reverse sequence. Since plasma 
glucose concentration is maintained (Goto et al, 2007) while plasma insulin concentration is 
reduced, carbohydrate oxidation will be the primary contributor to energy provision and thus 
additional uptake of NEFA for energy provision is not expected at the onset of resistance 
exercise. Thus, the baseline of a resistance bout of exercise preceded by an aerobic bout of 
exercise would likely not be different from rest and therefore not provide an advantage for 
enhanced substrate oxidation and/or energy expenditure.  
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Further investigation is needed to compare two different sequences (i.e. resistance 
followed by aerobic exercise and vice versa), with identical work volumes, to reveal any 
differences between the net changes in energy provision and substrate selection. This comparison 
will also provide greater insight into the mechanisms that influence substrate selection and 
utilization.  
 
2.4 Post-Exercise Recovery and Substrate Metabolism 
During recovery from a bout of aerobic exercise, fat oxidation continues to be elevated to 
a greater extent than carbohydrate oxidation (van Loon et al, 2003). Sustained elevation of 
NEFAs (Bahr et al, 1991; Kiens and Richter, 1998; Goto et al, 2007b; Henderson et al, 2007; 
Magkos et al, 2007) persist for up to 24 hours after cessation of aerobic exercise (Magkos et al, 
2007), which suggests increased mobilization of fatty acids from adipose tissue and/or reduced 
uptake of NEFAs by skeletal muscle. Plasma glycerol concentrations decline (Goto et al, 2007b) 
suggesting there may be depressed mobilization of fatty acids from adipose tissue and/or 
increased uptake of glycerol by liver for gluconeogenesis, which would be accompanied by a rise 
in glucagon. Epinephrine and norepinephrine are reduced in concert with increased insulin levels 
up to 30 minutes after cessation of aerobic activity (Goto et al, 2007b).  Taken together, 
increased mobilization of fatty acids from adipose tissue likely occurs despite decreases in 
glycerol. The decline in glycerol is likely explained by a greater rate of uptake by liver relative to 
its release from adipose tissue. With the redistribution of blood flow following exercise, more 
blood flow is likely re-distributed to the liver (Schoemaker et al, 1998), while there is a reduced 
flow to the skeletal muscles (compared to increased blood flow during exercise (Durham et al, 
2004)), which may enhance glycerol uptake by the liver. This in turn, would also explain the 
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elevated plasma NEFA concentrations that are reported (Goto et al, 2007b) as the rate of skeletal 
muscle uptake would likely be attenuated in relation to the reduced blood flow following 
exercise. However, the rise in insulin post-exercise would potentially continue to facilitate NEFA 
uptake via translocation of CD 36, as elevated catecholamine concentrations immediately post-
exercise promote NEFA mobilization from adipose tissue.  
During recovery from aerobic exercise, respiratory exchange ratio (RER) decreases, 
suggesting an increased reliance on fat oxidation post-exercise (Kuo et al, 2005). It is thought 
that fat oxidation will provide the energy required for glycogen re-synthesis via glycogen 
synthase (Bruce et al, 2001). Glycogen synthesis is controlled by substrate, covalent and 
allosteric modification. In particular, altered concentrations of glucose, G6P, insulin and 
glycogen have significant implications on glycogen synthesis (Graham and Shearer, 2002). Low 
glycogen content can itself stimulate glycogen synthase activity. Increased insulin 
concentrations, which are observed post-exercise, also activate glycogen synthesis, and facilitate 
GLUT4 translocation for glucose uptake. Once inside the muscle cell, glucose requires ATP to 
produce G6P using hexokinase; G6P ultimately becomes the key substrate and regulator of 
glycogen synthesis. To maintain adequate glucose supply for increased glycogen synthesis post-
exercise (Wojtaszewski et al, 2003), lactate from the preceding exercise is a precursor for liver 
gluconeogenesis.  
With increased glycogen re-synthesis following exercise, carbohydrate oxidation is 
simultaneously reduced (Richter et al, 1989; van Loon et al, 2003). Lower skeletal muscle AMP: 
ATP concentrations as well as lower intracellular Ca
2+
 and plasma epinephrine concentrations 
reduce glycolytic and glycogenolytic enzyme activity as well as AMPK stimulation of 
glycogenolysis.  Thus, less pyruvate is being produced, resulting in reduced PDH activity; 
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instead, acetyl-CoA production is derived from beta-oxidation (Mourtzakis et al, 2006). 
Ultimately, during recovery from aerobic exercise, carbohydrate oxidation is reduced as 
glycogen synthesis is a priority post-exercise and lipid oxidation is elevated to provide ATP for 
glycogen synthesis (van Loon et al, 2003).  
Similarly, during recovery from a bout of moderate-to-high intensity resistance exercise, 
there is a switch in substrate contribution from carbohydrate oxidation to increased lipid 
oxidation that remains elevated for up to 15 hours post- resistance exercise (Melby et al, 1993; 
Petitt et al, 2003; Singhal et al, 2009). Signals that activate the AMPK pathway through lower 
intracellular ATP concentration (i.e. muscle contraction) are reduced; thus, skeletal muscle shifts 
from substrate oxidation to synthesis to replenish glycogen stores. Therefore, although glucose 
uptake in exercising muscles remains elevated above pre-exercise values for at least 2 hours post 
exercise, whole body glucose oxidation is significantly depressed during recovery (Dreyer et al, 
2008) as glycogen is re-synthesized. While there are a few studies that have investigated the 
regulation of substrate metabolism following a bout of resistance exercise, understanding the 
interactions between lipid and carbohydrate utilization following resistance exercise warrants 
further evaluation. 
Aerobic and resistance exercise independently promote increased lipid oxidation during 
recovery (Melby et al, 1993; Kiens and Richter, 1998; Votruba et al, 2002; van Loon et al, 2003; 
Ormsbee et al, 2009). Thus, an exercise session, which includes both aerobic and resistance 
exercise, would be expected to also result in increases in lipid oxidation (relative to carbohydrate 
oxidation) immediately post-exercise. This would likely be indicated with a lower post-exercise 
RER in addition to elevated plasma NEFA concentrations. However, to date, there are no studies 
that have examined substrate selection and subsequent oxidation during post-exercise recovery 
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from a combined aerobic and resistance exercise session. It is unknown if the sequence in which 
aerobic and resistance exercise performed in the same session was altered (i.e. aerobic preceding 
resistance exercise versus resistance preceding aerobic exercise) would be most reflective of the 
second of the two exercises performed in the exercise session. That is, in an exercise session 
where a bout of resistance exercise is followed by a bout of aerobic exercise, would post-exercise 
substrate oxidation follow the same trends observed in recovery as would be observed from an 
independent bout of aerobic exercise? And, would the magnitude of post-exercise substrate 
oxidation be different depending on the type of exercise performed initially in the exercise 
sequence? 
It is a primary aim of this thesis to evaluate the effect of varying exercise sequence in a 
combined aerobic and resistance exercise session on energy and hormonal metabolism during the 





1. Examine whether the order in which aerobic and resistance exercise are performed in a 
single, combined exercise session, where the total amount of work is identical, influences 
carbohydrate and lipid oxidation differently during the individual aerobic and resistance 
exercise bouts in an aerobic-resistance versus a resistance-aerobic exercise sequence.  
 
2. Investigate the potential mechanisms for metabolic alterations in lipid and carbohydrate 
oxidation depending on the sequence of aerobic and resistance exercise in a single 
exercise session.  
 
3. Quantify the differences in energy expenditure that occur during and up to 30 minutes 
post-exercise, when the exercise sequence is altered. 
 
4. Assess the variability of blood metabolite measures and energy-related parameters when 
identical bouts of aerobic exercise are performed on two separate days to confirm that the 






1. The aerobic exercise bout performed in a resistance-aerobic exercise sequence will 
display increased NEFA and glycerol concentrations as well as lower plasma glucose 
concentrations and RER values. These changes in metabolic and energy-related 
parameters will correspond with greater contribution of lipid oxidation to energy 
provision, compared to a bout of aerobic exercise performed in an aerobic-resistance 
exercise sequence.    
 
2. A resistance-aerobic exercise sequence will be associated with a heightened sympathetic 
nervous system response characterized by higher concentrations of epinephrine, 
norepinephrine and glucagon during the exercise session and 30 minutes post-exercise, 
compared to an aerobic-resistance exercise sequence.  
 
3. During recovery, a resistance-aerobic exercise sequence will reduce plasma insulin 
concentrations, and maintain plasma glucose concentrations, while NEFA and glycerol 
concentrations will be elevated. In comparison, an aerobic-resistance exercise sequence 
will demonstrate reduced NEFA and glycerol concentrations, consistent with decreased 
mobilization of lipids from adipose tissue. RER will be lower for a resistance-aerobic 
exercise sequence as opposed to the alternate sequence indicating increased reliance on 
fat oxidation for energy provision when resistance exercise is performed prior to a bout of 
aerobic exercise.  
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4. Energy expenditure will be greater during the aerobic exercise bout as well as during 
recovery in a resistance-aerobic exercise sequence compared to an aerobic-resistance 
exercise sequence. Although the amount of work performed in each exercise session will 
be identical, performance of resistance exercise prior to aerobic exercise will result in 
greater fatigue of skeletal muscle which will reduce the mechanical efficiency of the 
exercising muscle and thus, more energy will be expended as muscle fiber recruitment 
increases to maintain the same work output (ie. cycling at 60% VO2 max for 30 min) as in 
the aerobic-resistance exercise sequence. Consequently, more glycogen, although not 
measured in this study, will be used for energy provision and a larger energy expenditure 
will be incurred during recovery from a resistance-aerobic exercise sequence as lipid 
oxidation is increased to a greater extent than with the opposite sequence to provide ATP 
for glycogen re-synthesis.  
 
5. Blood metabolite values and energy-related parameters (i.e. VO2, energy expenditure and 
RER) will not be significantly different when measured for two identical bouts of aerobic 
exercise that are performed on separate days. Since the aerobic exercise is performed 
under the same conditions, the hormonal response to cycling should activate regulatory 
enzymes (albeit not measured in this study) to the same extent and thus produce similar 
rates of carbohydrate and lipid oxidation as well as energy expenditure.  
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5.0 Study Design and Methods 
 
5.1 General Study Design  
Nine healthy, recreationally active males were recruited to participate in this study. This 
study comprised of an initial assessment to measure maximal oxygen consumption (VO2max), 
body composition, resting energy expenditure and maximal aerobic and strength capacity. The 
initial assessment was followed by three exercise trials that were comprised of: 1) a single bout 
of aerobic exercise (30 min at 60% VO2max), 2) aerobic exercise (30 min at 60% VO2max) 
followed by a 5 min rest and then a bout of resistance exercise (30 min at 70% predicted 1-RM), 
and 3) resistance exercise (30 min at 70% predicted 1-RM) followed by 5 min of rest and then a 
bout of aerobic exercise (30 min at 60% VO2max). The single aerobic bout (trial#1) was 
succeeded by an additional 30 min bout of aerobic exercise at the same intensity; however, only 
the first, single aerobic bout will be described and analyzed for the objectives of this thesis. All 
trials were separated by one week to minimize any lingering metabolic effects of previous 
exercise trials (Melby et al, 1993; Petitt et al, 2003; Magkos et al, 2007; Singhal et al, 2009); 
however, trials were not separated by greater than 1 week to maintain similar physical 
conditioning for each trial. The study received ethics clearance by the Office of Research Ethics 
at the University of Waterloo.  
 
5.2 Participants 
Eligible participants for this study were not previously diagnosed with any cardiovascular 
or respiratory disease or any condition that would prevent participation in exercise. In addition, 
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all participants engaged in less than 3 hours of structured physical activity each week. 
Maintaining similar activity levels and focusing on healthy males minimized disease-related 
effects, training effects and sex-related hormone fluctuations that could potentially influence the 
results of the study. Participants had a mean age of 25 ± 2 years (Range: 21 to 27 years). The 
average height, weight and body mass index (BMI) were 181.78 ± 6.26 cm (173.0 to 192.4 cm), 
78.82 ± 14.54 kg (59.3 to 102.6 kg), and 23.91 ± 4.50 kg/m
2
 (16.96 to 30.74 kg/m
2
), 
respectively.   
 
5.3 Initial Assessment 
Participants arrived for the initial assessment after an overnight fast. Participants were 
asked to avoid strenuous physical activity for 48 hours, consumption of caffeine for 24 hours, 
and alcohol consumption 24 hours; this minimized variability and confounding effects on 
metabolic measures and maintained consistent hydration. Participants were also asked to drive or 
use the bus to arrive to the laboratory to reduce any activity before the resting metabolic rate 
(RMR) assessment. During the initial assessment, RMR, body composition, aerobic and strength 
exercise capacity were determined in this respective order.  
RMR determination involved the participant lying supine on a bed in a quiet room for a 
total of 50 minutes. Oxygen consumption (VO2) was measured continuously using a Rudolph 
facemask and Vmax breath-by-breath system (Vmax; SensorMedics, Yorba Linda, CA). The 
data were reviewed and a five-minute period of steady-state oxygen consumption with minimal 
fluctuations in VO2 values and low corresponding respiratory exchange ratio values was selected 
from the 50 minutes of collected data for resting metabolic rate determination (Matarese, 1997). 
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The Weir equation (Weir, 1949) is a validated and frequently used tool to calculate resting 
energy expenditure (kcal/min) and it was utilized in this study: 
Resting energy expenditure (kcal/min) = (3.941*VO2*1000 + 1.106*VCO2*1000) *1.44  
Participants remained lying in a supine position on the bed for an evaluation of body 
composition using bioelectrical impedance analysis (BIA; RJL-101S; RJL Systems, Clinton 
Twp, MI). To minimize the chance of a false measure of increased lean tissue mass, removal of 
jewelry and voiding prior to BIA measurement is recommended. Voiding was not performed in 
this study. However, a pilot study was conducted on 5 subjects who were tested with a full 
bladder and re-tested with an empty bladder, and showed no statistical difference between the 2 
tests (Appendix 2). Two electrodes were placed on the dorsal surface of the participant’s right 
hand and two electrodes on the participant’s right foot. A low alternating current (50 Khz) was 
passed between electrodes on the hand and the electrodes on the foot. This produced a resistance 
and reactance value, which were input into an equation that was previously validated against 
dual-energy x-ray absorptiometry (DXA) in healthy males aged 18 to 94 years (Kyle et al, 2001):  
Fat free mass (kg) = -4.104 + 0.518*height
2
/resistance + 0.231*weight + 0.130*reactance 
+4.229 
To evaluate aerobic capacity, an incremental exercise test was performed on a cycle 
ergometer (Ergometrics 800; Ergoline, Deutschland, Germany) to fatigue. Briefly, heart rate was 
measured continuously using an electrocardiogram (EK 10; Spacelabs Burdick, Issaquah, 
Washington) and blood pressure was measured at rest and every two minutes during the exercise 
test using a manual sphygmomanometer. VO2 was also measured continuously using the 
Rudolph facemask and Vmax breath-by-breath system. Each participant started the test by 
pedaling at 50 Watts at a rate of 60 revolutions per minute (rpm). Rating of perceived exertion 
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(Borg, 1982) and blood pressure were recorded every 2 minutes. Pedaling resistance was 
increased by approximately 25 to 50 Watts every 2 minutes, depending on the increase in rating 
of perceived exertion between increments. The primary endpoint for this test was the 
participant’s inability to maintain an rpm of 60. Secondary endpoints included an RER value 
greater than 1.15 and a systolic blood pressure greater than 220 mmHg. VO2max was calculated 
using the average of the highest 3 values in the final work stage, and this was then used to 
calculate 60% VO2 max—the intensity at which the aerobic portion of each exercise trial was 
performed. The University of Waterloo Office of Research Ethics Standard Operating Procedure 
212 describes the incremental exercise test protocol in detail (Appendix 1). 
Following five minutes of rest, participants began the muscular strength evaluation. Since 
participants were untrained, a multiple repetition-maximum (RM) test was chosen to avoid injury 
while still challenging specific muscle groups to achieve close to a 1-RM. Based on the protocol 
from Kang et al (2009), exercises that involved large muscle groups were chosen to elicit the 
greatest metabolic response to a single resistance session. In sequential order, the resistance 
exercises that each participant performed were: overhead squat, chest press, triceps extension, 
shoulder press, and dead lift. For each exercise, the participant performed a warm-up of 10 
repetitions of the exercise at 50% of his estimated 1-RM. The participant was then given 1-2 
minutes to rest before completing 8-10 repetitions at 70% of his estimated 1-RM. After another 
1-2 minute rest, the participant completed his third set of 3-5 repetitions at 80 to 90% of his 
estimated 1-RM. The total repetitions and weight that was used during the last set for each 
exercise predicted maximal strength using the following equation from O’Conner et al (1989):  
Predicted 1-RM (lbs) = load lifted (lbs)/(1-0.025*number of repetitions completed) 
 28 
This equation assumes that a 1-RM represents 100% of the participant’s maximal 
strength and for every additional repetition that is completed, the load that is able to be moved 
will decrease by 2.5%. Seventy percent of the predicted maximal strength for each exercise was 
then determined for the resistance bout of each exercise trial.  
 
5.4 Exercise Trials 
Based on the Consolidated Standards of Reporting Trials statement, the order of 
completion for the three exercise trials was pre-determined using simple, unblocked 
randomization derived by a computerized random number generator (www.randomization.com); 
this minimized the potential for training effects from a prior exercise trial to influence the results 
of the subsequent trial. Trials were denoted as follows: aerobic (A), aerobic-resistance (AR) and 
resistance-aerobic (RA). Table 1 further describes the exercise sequence for each of the three 
trials. In addition, each session was performed after an overnight fast, and although not evaluated 
in this study, subjects were instructed to maintain the same diet for 2 days prior to each trial. This 
was to avoid any confounding effects of diet on carbohydrate and lipid oxidation for energy 
provision. Water was provided ad libitum during the entire exercise trial. Similar to the initial 
assessment, participants were asked to avoid strenuous physical activity for 48 hours, 
consumption of caffeine for 24 hours, and alcohol consumption 24 hours prior to each exercise 
trial to minimize variability in metabolic measures.  
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Table 1. Exercise sequence for each trial 
Denotation of Trial First exercise bout Second exercise bout 
A Aerobic n/a 
AR Aerobic Resistance 
RA Resistance Aerobic 
 
At the beginning of each trial, participants rested on a bed for approximately 5 minutes 
while a catheter was inserted into the anticubital vein of the participant’s preferred arm. 
Electrodes for electrocardiogram measures and a Rudolph facemask were fitted to continuously 
measure heart rate, VO2 and carbon dioxide output (VCO2), respectively, for the entire duration 
of each trial. To ensure consistency in data analysis between participants, the last 10 minutes of 
respiratory data collected for both the first and the second bout of exercise during each trial was 
analyzed.  
During the A trial, participants performed 30 minutes of cycling on a stationary cycle 
ergometer at 60% VO2max. The AR and RA trials also consisted of 30 minutes of cycling at 60% 
VO2max during the aerobic portion of the exercise. The resistance bout of each trial was 
comprised of the 5 exercises performed during the initial assessment. For each exercise, the 
participant performed 3 sets of 8 repetitions at 70% predicted 1-repetition maximum (1-RM) in 
the following order: overhead squat, chest press, triceps extension, shoulder press, and dead-lift. 
Each bout of exercise was separated by a five-minute rest period and after completion of the two 
bouts of exercise, participants rested on the bed for 30 minutes, while remaining in a fasted state.  
For participants who were unable to maintain their predicted aerobic intensity (for 
example, the participant was unable to maintain 60 rpm or greater) over the 30-minute exercise 
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bout, the work rate was reduced by 10 Watts until the subject was able to pedal at 60 rpm, which 
was then maintained for the duration of the aerobic exercise bout. To ensure that participants 
maintained a 60% work intensity, VO2 values during the exercise trial were compared with the 
predicted 60% VO2 values from the initial assessment. This work rate adjustment was made 
during the first aerobic bout completed by the participant, regardless of exercise trial, and was 
maintained for all subsequent aerobic trials to ensure that the participant exercised at the same 
workload for each trial.  
The exercise intensities chosen for this study were based on previous work that examined 
substrate utilization in combined aerobic and resistance exercise when exercise sequence was 
varied (Goto et al, 2007b; Kang et al, 2009). Cycling at 60% VO2max is regarded as moderate 
intensity aerobic exercise where steady state can be established within 3-4 minutes of initiation 
(Wasserman et al, 2005). In untrained individuals, elevated glycolytic rates and carbohydrate 
oxidation would most likely be maintained at this intensity for the duration of the exercise bout. 
The resistance exercise protocol is similar to protocols previously employed to evaluate substrate 
oxidation during this type of exercise (i.e. each exercise is performed at 70% 1RM for 3 sets 
(~30 min)) (Kang et al, 2009), which is a feasible volume of work for this group of untrained 
males to complete. Additionally, this intensity and volume of work will largely stimulate of 
glycolysis. The extent to which each parameter deviates from rest can be compared between 
exercise sequences for differences in substrate oxidation and energy expenditure.  
Blood samples (8.5mL) were drawn at five time points during each trial: before 
beginning the first exercise bout, before and after the second exercise bout and at 15 and 30 
minutes post-exercise. Figure 2 summarizes the timeline for blood collection during each 
exercise trial.  
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Figure 2. Exercise Trial Timeline; arrows indicate an 8.5 mL blood draw for: glucose, insulin, 
C-peptide, glucagon, lactate, glycerol, NEFA, triacylglyerol, epinephrine and norepinephrine 
 
5.5 Blood Analyses 
Blood was analyzed for: non-esterified fatty acids (NEFA), glycerol, glucose, insulin, C-
peptide, glucagon, epinephrine, norepinephrine and lactate. In addition, a lipid profile 
(triacylglycerol (TAG), high-density lipoprotein (HDL) and low-density lipoprotein (LDL)) was 
completed at pre-exercise time-points for each participant to establish a more detailed 
characterization of the study participants.  
Serum was collected for glucose, insulin, C-peptide, lactate, NEFAs and glycerol. Whole 
blood was given 30 minutes standing time to clot and then centrifuged at 2500 rpm for 10 
minutes at room temperature. Plasma samples for measuring glucagon were prepared by adding 
2 mL of whole blood to test tubes containing 80 µL of combined aprotinin and 
ethylenediaminetetraacetic acid (an anti-coagulant). Similarly, for catecholamines, 3mL whole 
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blood was added to test tubes containing 75µL of combined EGTA/Glutathione (also an anti-
coagulant). The test tubes were then set on ice for the duration of the trial and were subsequently 
centrifuged at 2800 rpm for 15 minutes at 4˚C.   
All samples were aliquoted into a separate eppendorf for each metabolic measurement to 
avoid multiple freeze and re-thaw cycles. All samples were stored at -80˚C. All samples, unless 
otherwise indicated, were run in triplicate and the average measure for the two readings with the 
lowest co-efficient of variance (COV) was used as the final value. Appendix 3 lists the mean 
COV as well as the range of COVs for each metabolite reported.  
 
5.5.1 Serum Glucose 
Serum glucose was measured using a spectrophotometer (UV160U; Shimadzu, 
Columbia, MD). Test tubes were filled with 10 µL of distilled water (also termed the blank; 
providing a measure of background variability), glucose standard or sample. A reagent solution 
(Sigma-Alderich, St. Louis, MO, USA) with active ingredients glucose oxidase, peroxidase, and 
o-Dianisidine dihydrochloride was prepared and 2500 µL of this solution was added to each test 
tube. After vortexing, the test tubes were incubated for 30 minutes in at 37°C waterbath. When 
the glucose in the solution reacts with glucose oxidase, hydrogen peroxide is liberated. 
Peroxidase catalyzes the reaction between hydrogen peroxide and o-Diansidine dihydrochloride 
to form oxidized o-Dianisidine. O-Dianisidine is often used in analytical tests to produce a color 
change that can be detected by the spectrophotometer. The intensity of the final product, 




5.5.2 Serum Insulin 
Insulin concentration was measured, in duplicate, using a Coat-A-Count Insulin 
Radioimmunoassay kit (Siemens Healthcare Diagnostics; Deerfield, IL). 200 µL of standard, 
blank or sample were added to insulin-antibody coated polypropylene test tubes. 1 mL of 
125
I-
labeled insulin was added to each test tube and subsequently vortexed.  
125
I-labeled insulin 
competes with insulin from the sample for sites on insulin-specific antibody that is immobilized 
to the test tube walls. After incubating for 24 hours at room temperature, the supernatant in each 
test tube was aspirated. A gamma counter (Wallac Wizard 1470 Automatic Gamma Counter; 
PerkinElmer Life and Analytical Sciences, Woodbridge, ON) measured the amount of 
125
I-
labeled insulin bound to the insulin antibody and using a calibration curve, computed the insulin 
concentration for each sample.  
 
5.5.3 Serum C-Peptide 
Serum C-peptide is a marker of insulin release since it is by-product when pro-insulin is 
cleaved to form insulin. Thus, C-peptide is released in a 1:1 ratio with insulin. This measurement 
is useful to distinguish between elevated insulin concentrations attributed to increased insulin 
release (where C-peptide would be proportionally elevated) or reduced insulin clearance (where 
C-peptide would be reduced). Using the Human C-Peptide radioimmunoassay kit (Siemens 
Healthcare Diagnostics; Deerfield, IL), 100µL of serum is combined with 100µL each of 
125
I-
Human C-Peptide and 100µL of Human C-Peptide antibody. The sample is vortexed and 
incubated at 4˚C for 20-24 hours before a precipitating reagent is added to the mixture. The 
sample is then vortexed and incubated again, for 20 min at 4˚C. Subsequent centrifugation (15 
minutes at 3000g) separates the sample into a precipitate and supernate, which is aspirated. The 
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solid precipitate is then placed in a gamma counter (Wallac Wizard 1470 Automatic Gamma 
Counter; PerkinElmer Life and Analytical Sciences, Woodbridge, ON) for 1 minute. The 
concentration of C-peptide (ng/mL) for each sample is determined by extrapolation from a 
concentration curve, which is plotted after performing the same procedure described above on 
samples of known C-Peptide concentrations.   
 
5.5.4 Plasma Glucagon 
Glucagon analysis is completed with a double-antibody radioimmunoassay test (Siemens 
Healthcare Diagnostics; Deerfield, IL). 
125
I-labeled glucagon competes with glucagon in the 
sample for sites on glucagon-specific antibodies. 200 µL of calibrator or sample were combined 
with 100 µL of glucagon anti-serum in test tubes. All test tubes were vortexed and incubated at 
4°C for 24 hours. 100 µL of 
125
I-labeled glucagon is then added to all of the test tubes, which are 
subsequently vortexed and incubated for an additional 24 hours at 4°C. 1 mL of cold 
precipitating solution (ingredients: goat anti-rabbit gamma globulin and dilute polyethylene 
glycol in saline) was added to the test tubes which were then vortexed and centrifuged for 15 
minutes at 1500g. Precipitated solid was isolated through aspiration of supernatant and each test 
tube was counted for 1 minute on a gamma counter (Wallac Wizard 1470 Automatic Gamma 
Counter; PerkinElmer Life and Analytical Sciences, Woodbridge, ON). Glucagon concentration 




5.5.5 Plasma Catecholamines 
Plasma catecholamine concentrations, specifically epinephrine and norepinephrine, were 
determined using high performance liquid chromatography. For this assay, 1 mL of plasma from 
each time point was added to a microcentrifuge tube that contained 20 mg acid washed alumina, 
400 µL 2.0 M Tris + 2% EDTA and 50 µL of 3,4-dihydroxybenzylamine.  The samples were 
then mixed by inversion for 45 minutes. The catecholamines became bound to the alumina, 
allowing for extraneous metabolites in the plasma sample to be removed when each 
microcentrifuge tube was washed with distilled water (repeated with three additional washes). 
100 µL of 0.1 M perchloric acid was then added to the catecholamine-bound alumina to release 
the catecholamines back into solution. The microcentrifuge tube was vortexed and centrifuged 
before 50 µL of supernatant was injected into the HPLC column. The concentration of each 
sample was calculated based on a standard curve that was derived from known concentrations as 
well as an internal standard, which was 3,4-dihydroxybenzylamine.   
 
5.5.6 PCA Extraction for Lactate and Glycerol Samples 
To remove extraneous protein that interferes with the true reading of serum metabolite 
concentration, lactate and glycerol samples underwent a PCA extraction before being measured 
in their respective assays. Test tubes containing 500 µL of 0.6M perchloric acid were set on ice 
and 100 µL of serum from each sample was added to individual test tubes. Following 
centrifugation at 4°C for 2 min at 15,000 rpm, 250 µL of 1.25M potassium bicarbonate was 
added to each test tube and allowed to set for 10 min. Centrifugation was repeated and 
supernatant was transferred to eppendorfs for storage at -80°C and a dilution factor of 8.5 was 
used for calculating final concentrations of lactate and glycerol.  
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5.5.7 Serum Lactate 
Serum lactate was measured using a spectrofluorophotometer (RF-1501; Shimadzu, 
Columbia, MD). The reagent solution contained 15 mL hydrazine, 15 mL glycine and 1500 µL 
NAD
+
 was prepared, brought to 150 mL volume using distilled water and adjusted to a pH of 
10.0.  Lactate dehydrogenase was diluted mixing 250 µL of lactate dehydrogenase (Sigma-
Alderich, St. Louis, MO, USA) (5200 U/mL) with 1 mL of the reagent solution. 25 µL of blank, 
lactate standard and sample were added to each test tube in triplicate. Subsequently, 1 mL of 
dilute reagent was added to each test tube and each tube was then vortexed. A baseline reading 
was performed on the flurometer (measurement settings: 365nm to 455nm). 25 µL of dilute 
lactate dehydrogenase was additionally added to all of the test tubes before being vortexed and 
placed in the dark to incubate for 120 minutes. Lactate in the test tubes is oxidized to pyruvate by 
lactate dehydrogenase. Hydrazine in the dilute reagent solution breaks down the lactate, allowing 
complete oxidation of lactate. Following the incubation period, a final reading was completed on 
each tube. The wavelengths for each sample were determined by subtracting the initial baseline 
reading from the final reading. NAD
+
 from the dilute reagent solution was reduced to NADH 
which fluoresces in direct proportion to the concentration of lactate in each sample. The 
concentration of lactate was then calculated based on a regression equation created from the 
standard curve between the blank and lactate standard of known concentrations.  
 
5.5.8 Serum Glycerol 
To measure serum glycerol, a dilute 100 mL reagent solution was prepared from 5 mL 
hydrazine, 20 mL glycine, 160 µL NAD
+
, 40 µL ATP, 100 µL MgCl2, 500 µL cysteine and 50 
µL of glycerol-3-phosphate dehydrogenase (Roche Diagnostics, Indianapolis, IN, USA). 50 µL 
 37 
of sample was placed in a test tube and combined with 1 mL of dilute reagent. A baseline 
reading was performed on the spectrofluorophotometer (RF-1501; Shimadzu, Columbia, MD), 
with absorbance parameters between 365 to 455nm. 10 µL of dilute glycerol kinase (glycerol 
kinase (450 U/mL in 1 mL of dilute reagent) (Boehringer Mannheim, Germany)) was added to 
each test tube, vortexed and then incubated in a dark drawer for 60 minutes. In the presence of 
glycerol kinase, serum glycerol reacts with ATP to form glycerol-3-P. Glycerol-3-P combines 
with NAD
+
 from the reagent solution to yield dihydroxyacetone phosphate and more important 
to this assay, NADH, a fluorescing marker of glycerol concentration. The absorbance of NADH 
in the spectrofluorophotometer is proportional to the concentration of glycerol in each sample. A 
second reading on the spectroflurophotometer was taken for each sample after the incubation 
period and concentrations were determined using a standard curve derived from known 
concentrations of five glycerol standards.  
 
5.5.9 Serum Non-Esterified Fatty Acids 
Serum non-esterified fatty acids (NEFA) concentrations were evaluated using a Wako 
NEFA-HR(2) kit (Wako Diagnositics; Richmond, VA) and 96 well microplate. 5 µL of water 
(blank), standard or sample were added to separate wells. 200 µL of Color Reagent A solution, 
containing acyl-coenzyme A synthase, coenzyme A, ATP and 4- aminoantipyrine, was added to 
all of the wells and the microplate was incubated in the spectrophotometer (Spectramax Plus 
384; Molecular Devices, Sunnyvale, CA) for 5 minutes at 37˚C.  During the incubation, acyl-
COA synthase reacted with the serum NEFAs in the presence of coenzyme A and ATP to form 
by-products, in particular, acyl-COA. Following incubation, the absorbance of each well was 
measured at 550 nm. 100 µL of Color Reagent B solution (main ingredients: acyl-coenzyme A 
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oxidate and peroxidase) was then added to each well and the microplate underwent an additional 
5 minutes of incubation at 37˚C. When Color Reagent B solution was mixed with the previously 
incubated solution in the wells, acyl-CoA was oxidized (via acyl-CoA oxidase) to produce 
hydrogen peroxide. Hydrogen peroxide was then available to catalyze the final end-product 
formation from 4-aminoantipyrine, which fluoresces in direct proportion to the concentration of 
NEFA present in each sample. The absorbance of each well was obtained a second time and the 
final absorbance for each sample was determined by subtracting the first absorbance reading 
from the second absorbance reading. Sample concentrations were calculated using the following 
equation provided by the Wako Diagnostics kit:  
Sample Concentration (mmol/L) = standard concentration X (sample absorbance/standard 
absorbance) 
 
5.5.10 Serum Triacylglycerol 
Fasting triacylglycerol concentrations were measured using a kit (Genzyme Diagnostics 
Inc., P.E.I., Canada) and samples were run in quadruplicate. 12.5 µL of blank, standard or 
diluted sample were added to test tubes. 125 µL of reagent (active ingredients: ATP, 4-
aminoantipyrine, peroxidase, glycerol phosphate oxidase, glycerol kinase, 3,5-dichloro-2-
hydroxy-benzenesulfonic acid and lipase) was added to each test tube and all samples were 
incubated at room temperature for 10 minutes. While incubating, lipase catalyzes the degradation 
of triacylglycerides into glycerol and NEFA. Glycerol combines with ATP in a reaction 
catalyzed by glycerol kinase to produce glycerol-1-phosphate. In the presence of glycerol 
phosphate oxidase, the newly formed glycerol-1-phosphate reacts with oxygen to form hydrogen 
peroxide. In the final reaction, hydrogen peroxide, via peroxidase, mixes with 4-aminoantipyrine 
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and 3,5-dichloro-2-hydroxy-benzenesulfonic acid producing a quinoneimine dye. The 
absorbance of the quinoneimine dye in each test tube is measured at 520 nm on a 
spectrophotometer (Spectramax Plus 384; Molecular Devices, Sunnyvale, CA); the absorbance 
of the dye is directly proportional to the concentration of triacylglycerides in the sample.  
 
5.5.11 Serum Total Cholesterol 
Fasting serum cholesterol was evaluated using a prepared kit (Diagnostic Chemicals Ltd, 
P.E.I., Canada). Test tubes containing 25 µL of blank, cholesterol standard or sample were 
mixed with 2.5 mL of cholesterol working reagent (main ingredients: 4-aminoantipyrine, 
cholesterol esterase, cholesterol oxidase, phenols). After mixing, the test tubes were incubated in 
a water bath set at 37˚C for 5 minutes. When serum cholesterol was mixed with the working 
reagent, cholesterol oxidase catalyzed the conversion of free cholesterol to cholesten-3-one and 
hydrogen peroxide. The hydrogen peroxide generated then reacted with 4-aminoantipyrine and 
phenol to produce quinoneimine, a chromogen. Using a spectrophotometer (Spectramax Plus 
384; Molecular Devices, Sunnyvale, CA) set at 505 nm, the absorbance for each sample was 
determined. Total cholesterol concentration was directly proportional to the color intensity of the 
chromogen in each sample.  
 
5.5.12 Serum High-density Lipoprotein 
To measure high-density lipoprotein (HDL), 2 µL of blank, HDL standard or serum was 
added to separate wells in a 96 well microplate. A HDL kit (Genzyme Diagnostics, Framingham, 
MA) provided 2 reagents that were added to the wells. 200 µL of the first reagent, containing 
antihuman β-lipoprotein antibody, was added to each well, vortexed and incubated at 37˚C for 10 
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minutes in the spectrophotometer (Spectramax Plus 384; Molecular Devices, Sunnyvale, CA). 
The 96 well microplate was mixed using the spectrophotometer plate mixer every 1-2 minutes 
for the duration of the incubation period. The absorbance of each sample was read at 550 nm 
before 100 µL of a second reagent (main ingredients: cholesterol esterase, cholesterol oxidase, 4-
aminoantipyrine, peroxidase) was added to all wells. The microplate was vortexed before 
undergoing an additional 10 minutes of incubation (with slight agitation using the plate mixer) in 
the spectrophotometer at 37˚C. The addition of antihuman β-lipoprotein in each well liberates 
free HDL by binding with all lipoproteins in serum, excluding HDL. HDL is then oxidized by 
cholesterol oxidase to produce hydrogen peroxide. In the presence of peroxidase, hydrogen 
peroxide couples with 4-aminoantipyrine to form a blue-dyed chemical complex. The absorbance 
of the final product in each well was measured at 550 nm and concentrations were calculated 
using a standard curve derived from the blank and HDL standard concentrations.  
 
5.5.13 Serum Low-density Lipoprotein 
Fasting serum low-density lipoprotein (LDL) was indirectly assessed, due to cost and kit 
availability limitations. The following equation (Friedewald et al, 1972) was provided by 
Diagnostic Chemicals Ltd (P.E.I., Canada) and estimates LDL concentration:  
LDL (mmol/L) = total cholesterol – HDL – (TAG*2.2)  
Total cholesterol, HDL and TAG were measured directly with the procedural details 




Fat oxidation that occurred during the aerobic bout of activity for each trial was estimated 
using the respiratory exchange ratio (RER) value recorded by the Vmax system (Vmax; 
SensorMedics, Yorba Linda, CA). To further evaluate energy expenditure during exercise, the 
following equation was used:  
Energy expenditure (kcal/min) = 0.550*VCO2 – 4.471*VO2  (Jeukendrup and Wallis, 2005) 
The derivation of this equation was made based on the assumption that the contribution 
of carbohydrate oxidation to energy expenditure is fulfilled by plasma glucose (20%) and muscle 
glycogen (80%) when exercise is performed at moderate intensities (50 to 75% VO2 max).  For the 
evaluation of energy expenditure during recovery, the Weir equation (Weir, 1949) was used: 
Resting energy expenditure (kcal/min) = (3.941*VO2*1000 + 1.106*VCO2*1000) *1.44  
Respiratory measures were used to estimate potential differences in carbohydrate and 
lipid oxidation rates during the aerobic exercise portion of the AR trial compared to the RA trial, 
where the aerobic portion of the latter sequence is preceded by resistance exercise. The last 10 
min of VO2 and VCO2 values for each aerobic exercise were averaged and incorporated into 
Frayn’s equations (1983): 
Carbohydrate oxidation (g/min) = 4.55*VCO2 – 3.21*VO2 – 2.87*n 
Lipid oxidation (g/min) = 1.67* VO2 – 1.67*VCO2 – 1.92* n 
Where n represents nitrogen excretion rate that was estimated to be 135µg/kg/min 





Area under the Curve (AUC) calculations  
To measure AUC for the AR and RA trials, a graph of glucose and insulin concentration 
vs. time were separately created for each participant. Area under each curve was calculated for 
the following time periods: 1) 0 to 30 min to represent changes in the first bout of exercise, 2) 30 
to 60 min to depict changes in the second bout of exercise, 3) 60 to 75 min to examine changes 
immediately post-exercise, and 4) 75 to 90 minutes to illustrate changes in early recovery. Total 
Exercise AUC reflects changes in plasma glucose concentration over the entire duration of 
exercise (0 to 60 min), while Total Recovery AUC displays changes in plasma glucose 
concentration from immediately post- to 30 min post-exercise (60 to 90 min).  
 
5.7 Statistical Analyses 
Data collected from this study were reported as means ± standard deviation (SD). All 
power calculations and results were analyzed using SigmaPlot 11.0 (Systat Software Inc, SPSS, 
San Jose, CA) and values with a p-value of <0.05 were considered significant. For statistically 
significant data, Tukey’s post-hoc analysis was employed to identify the trial and time point 
where the difference occurred. Trends will be identified were p<0.15. 
 
5.7.1 Statistical Power and Sample Size 
Based on the study results for primary measures used to evaluate lipid and carbohydrate 
metabolism (i.e. glycerol, NEFA, glucose and respiratory exchange ratio (RER)), a sample size 
that would achieve 80% statistical power was calculated for each of the primary parameters 
described above. For these power calculations, the difference in value between the AR and RA 
exercise trials, as well as the standard deviation of the difference in means, was determined by 
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subtracting the value measured at 0 min from the value measured at 60 min, for each parameter.  
Power was re-calculated after data collection for the same primary measures (i.e. glycerol, 
NEFA, glucose and RER) to identify the statistical power that was achieved with the study’s 
actual sample size (n=9). The results are presented in Appendix 4.  
 
5.7.2 Comparison of Metabolite and Energy Parameters during Exercise in the AR and RA 
Trials 
To evaluate the effect of exercise order on changes in metabolite concentrations and 
energy-related parameters, AR and RA exercise trials were evaluated using a two-way repeated 
measures ANOVA (time x exercise sequence). Specifically, baseline (0 min) was compared to 
the completion of the first exercise bout (30 min) and the completion of the second exercise bout 
(60 min), which were in turn compared between the AR and RA trials. Baseline (0 min) 
respiratory measures (i.e. VO2, EE and RER) were calculated from data obtained during the 
initial assessment, as resting values for these parameters were not collected during the exercise 
trials.  
 
5.7.3 Comparison of Metabolite and Energy Parameters after the Completion of an Aerobic 
Exercise Bout in the AR and RA trials 
  To assess differences in metabolite concentrations and values for energy 
parameters between an aerobic bout of exercise in the AR and RA trials, a two-way repeated 
measures ANOVA (time x exercise sequence) was used. Statistics were generated for both pre- 
and post- aerobic exercise, however only post-aerobic exercise values were investigated. In both 
trials, there is a break that is followed by the first exercise session prior to the onset of the second 
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exercise session. For logistical reasons, respiratory data collection stopped with the cessation of 
the first exercise bout and blood samples were collected immediately following each exercise 
bout (prior to a 5 min rest period). While post-exercise values can be accurately compared with 
the data collected, pre-exercise values cannot be compared between trials because metabolite 
concentrations and energy parameters may have changed over the 5 min rest period, and thus 
may not be reflective of starting concentrations for the subsequent aerobic exercise bout in the 
RA trial.  
 
5.7.4 Comparison of Metabolite and Energy Parameters Recovery in the AR and RA Trials 
To investigate the effects of exercise sequence on post-exercise recovery following an 
AR or RA exercise trial of the same total work volume, changes in metabolite concentrations and 
energy-related parameters immediately post-exercise (60 min), 15 minutes into recovery (75 
min) and 30 minutes into recovery (90 min) were also compared between time points and 
between trials. Post-exercise recovery data for VO2, RER and EE data at 60 min was collected 
for the first 5 minutes immediately post-exercise. It is therefore different from the data reported 
for these parameters at the 60 min time point for the exercise portion of the trial, which was 
calculated using the last 10 minutes of data from the exercise bout.  
Area-under-the-curves (AUC) were calculated for glucose and insulin to examine the 
amount of circulating plasma concentrations over the duration of exercise and recovery relative 
to rest.  
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5.7.5 Evaluation of Variability in Metabolite and Energy Parameters during an Aerobic Exercise 
Bout Completed on Two Separate Days 
Variation in performing a single bout of aerobic exercise on two separate days was 
evaluated (A trial vs aerobic portion of AR trial) for each measurement at baseline (0 min) and 
immediately post-exercise (30 min). Bland-Altman plots (Bland and Altman, 1986) were created 
for NEFA, glycerol, glucose, insulin, epinephrine and norepinephrine, the primary parameters 
used to assess carbohydrate and lipid oxidation and energy expenditure for this study. Bland-
Altman plots were also created for VO2 and RER immediately post-exercise (30 min), as 
baseline data for these parameters was taken from the initial assessment which was identical for 
both the A and AR trial.  The A trial served as a control and the results for the aerobic portion of 
the AR trial were expressed as units of standard deviation from the results calculated for the 






6.1 Baseline Characteristics 
Despite the tight range in age, fasting glucose as well as the number of hours reported for 
weekly physical activity (<3 hours / week), the group of participants that was studied was 
heterogeneous with respect to body composition, metabolic profile, resting energy expenditure, 
and maximal aerobic capacity (Tables 2 and 3). Individual predicted 1-RM strength testing also 
revealed heterogeneity among study participants. The average predicted 1-RM for the overhead 
squat, chest press, triceps extension, shoulder press and dead-lift exercises completed in this 
study were 64 ± 28, 125 ± 58, 60 ± 24, 71 ± 37 and 168 ± 80 kg, respectively. Mean BMI was 
23.9 ± 4.5 kg/m
2
, which represents a healthy BMI classification (WHO, 1995). However, one 
participant was underweight with a BMI of 17 kg/m
2
, two participants were classified as 
overweight (27.72 and 28.37 kg/m
2
), and one participant was obese (BMI: 30.6 kg/m
2
). This 
range of classifications also coincides with the range of fat and fat-free mass measurements 
observed in this group (Table 2). Variability was also reflected in the range of measurements for 
the fasting lipid profile of the participants (Table 3). With the aim to focus on untrained 
individuals, the heterogeneity observed in these parameters was expected from this group of 
male participants. 
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Table 2. Physical Characteristics of Participants at Initial Assessment 
 Mean ± SD Range 
Age (yrs) 25 ± 2 21 to 27 
Weight (kg) 78.8 ± 14.5 59.3 to 102.6 
Height (cm) 181.8 ± 6.3 173.0 to 192.4 
BMI (kg/m
2
) 23.9 ± 4.5 17.0 to 30.6 
Body Fat (%) 22 ± 6 14.0 to 31.4 
Whole Body Fat Mass (kg) 18 ± 7 9 to 31 
Whole Body Fat Free Mass (kg) 61 ± 8 51 to 78 
REE (kcal/day) 1635 ± 258 1379 to 2120 
REE (kcal/kg/day) 21.0  ± 2.4 17.8 to 24.5 
VO2max (mL/kg/min) 39.52 ± 5.96 29.40 to 47.96 
 
 
Table 3. Metabolic Profile of Participants Following an Overnight Fast  
 Mean + SD Range 
TAG (mM) 1.15 + 0.89 0.44 to 3.29 
LDL (mM) 2.23 + 0.85 0.78 to 3.72 
HDL (mM) 1.33 + 0.33 0.92 to 1.78 
Total Cholesterol (mM) 4.08 + 1.03 2.11 to 5.62 
Total Cholesterol/HDL Ratio 3.2 + 1.1 1.9 to 5.2 
Glucose (mM) 4.51 + 0.39 3.83 to 4.89 
 
 
6.2 Substrate Oxidation during Exercise  
RER values increased from rest to 30 min, for both the AR and RA trials (AR: 0.81 ± 
0.05 to 1.27 ± 0.90 and RA: 0.81 ± 0.05 to 1.07 ± 0.07, p<0.05; Table 4). At 60 min, RER was 
significantly elevated in the AR trial compared to rest and 30 min. In the RA trial, RER was 
reduced compared to 30 min (p<0.05), although it was still significantly elevated compared to 
rest. While RER was significantly different between trials at 30 and 60 min (p<0.05), RER 
values were similar at the completion of the aerobic exercise bout for both the AR and RA trial. 
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This suggests that exercise sequence does not affect substrate oxidation during an acute bout of 
aerobic exercise. 
 Carbohydrate oxidation rates were similar between the aerobic exercise bouts of both 
trials (AR: 2.49 ± 0.69 vs. RA: 2.47 ± 0.64 g/min). Fat oxidation rates were also similar between 
the aerobic bouts of the AR (0.15 ± 0.09 g/min) and RA (0.19 ± 0.09 g/min) trial.   
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Table 4. Metabolite Concentrations at Baseline and at Completion of Exercise  




























































































































 2.50 ± 0.94 2.96 ± 1.00 2.35 ± 0.89 













1. Data are reported in mean ± SD 
2. * Denotes a significance level of p<0.05 between trials 
3. Different letters denote a significance level of p<0.05 between time points (0 vs. 30 vs. 60 min) within a trial 
4. ǂ Denotes a significance level of p<0.05 between the aerobic exercise bouts of the AR (30 min) and RA (60 min) trial or between 
resistance exercise bouts of the AR (60 min) and RA (30 min) trial 
5. VO2, EE and RER data for baseline measures were taken from the initial assessment   
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Plasma NEFA concentrations remained unchanged from rest throughout the entire 
exercise duration of the AR trial (0.349 ± 0.150 mM at 0 min, 0.356 ± 0.156 mM at 30 min, and 
0.288 ± 0.084 mM at 60 min, p>0.05; Table 4). In the RA trial, NEFA concentrations were 
reduced from 0.412 ± 0.171 to 0.243 ± 0.096 mM by the completion of the first bout of 
resistance exercise (30 min, p<0.05), but increased during the aerobic exercise bout to return to 
values similar to rest by 60 min (0.36 ± 0.175; p>0.05). Thus, both trials depicted no differences 
between NEFA concentrations at the end of aerobic exercise relative to rest. While there were no 
significant differences observed in NEFA concentrations between AR and RA trials, NEFA 
concentrations tended to be greater at 30 min in the AR trial compared to the RA trial (p=0.056; 
Table 4). Plasma glycerol was significantly higher immediately after the first bout of exercise (at 
30 min) for the AR trial compared to the RA trial (145.77 ± 51.96 vs. 96.81 ± 42.11 mM, 
respectively, p<0.05; Table 4). Glycerol concentrations remained elevated during the resistance 
portion of the AR trial compared to rest; in contrast, glycerol concentrations increased after the 
completion of the aerobic exercise bout (at 60 min) in the RA trial compared to 0 and 30 min 
(p<0.05). In addition, glycerol concentrations increased during each aerobic exercise bout and 
tended to be higher at 60 min in the RA trial compared to 60 min in the AR trial (p=0.105; Table 
4).  
Epinephrine (Figure 3A) and norepinephrine (Figure 3B) concentrations were increased 
from rest at the completion of the first bout of exercise (from 0 to 30 min; p<0.05) and remained 
elevated for the second exercise bout (30 versus 60 min; p>0.05) for both the AR and RA trials. 
A comparison of the aerobic exercise bouts in both trials showed significantly higher epinephrine 
concentrations during the RA trial as opposed to the AR trial (AR: 60.41 ± 55.29 vs. RA: 73.01 ± 
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31.58 pg/mL; Table 5).   In addition, there was a trend observed for norepinephrine 










































Figure 3. Changes in epinephrine (A) and norepinephrine (B) concentration from rest (0 min) to 
completion of exercise (60 min). * denotes a significant difference of p<0.05 between trials; 
different letters denote a significance level of p<0.05 between time points (0 vs. 30 vs. 60 min) 
within a trial. ǂ denotes a significance level of p<0.05 between the aerobic exercise bout of the 





During the aerobic exercise of each trial, plasma glucose was maintained (AR: 4.53 + 
0.41 mM at 0 min versus 4.50 ± 0.58 mM at 30 min; RA: 5.18 ± 0.54 mM at 30 min versus 4.87 
+ 0.39 mM at 60 min; Table 4 and Figure 4A). Plasma glucose at the end of the aerobic exercise 
bout from each trial was not different from rest, however it was significantly elevated after 
aerobic exercise in the RA trial compared to the AR trial (AR: 4.50 ± 0.58 vs. RA: 4.87 ± 0.39 
mM; Table 5).  Plasma glucose was increased after the completion of the resistance exercise for 
both trials and was elevated relative to rest for both trials (p<0.05; Figure 4A). Glucose AUC 
during exercise did not differ between trials, however, both trials tended to be elevated for the 
second bout of exercise (p=0.115; Figure 4B). There were no differences in total glucose AUC 
between either trial.  
During the AR trial, plasma insulin concentrations decreased after a bout of aerobic 
exercise (30 min) and remained depressed following a bout of resistance exercise (60 min, 
p<0.05; Figure 5A). In contrast, in the RA trial, insulin concentrations were maintained during 
the first bout of exercise (30 min) relative to rest (0 min) before declining in the aerobic exercise 
bout (p<0.05). Insulin concentrations were significantly lower at 30 min in the AR trial 
compared with the RA trial (AR: 5.24 ± 2.65 µU/mL at 0 min to 2.54 ± 1.92 µU/mL at 30 min 
vs. RA: 4.95 ± 2.64 µU/mL at 0 min to 4.71 ± 1.86 µU/mL at 30 min). AUC for insulin during 
exercise was significantly elevated during the 2
nd
 bout of exercise (30 to 60 min) compared to the 
1
st
 bout of exercise (0 to 30 min, p<0.05; Figure 5B) for both trials. Similar to insulin, C-peptide 
concentrations, as expected, were also lower at 30 min in the AR trial (2.18 ± 0.91 ng/mL) 
compared to the RA trial (2.96 ± 1.00 ng/mL). C-peptide tended to be greater at 60 min vs. 30 
min in the AR trial (2.54 ± 1.16 vs. 2.18 ± 0.91 ng/mL, p=0.089; Table 4) and was significantly 
higher after completion of the aerobic exercise bout in the RA trial as opposed to the AR trial 
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(AR: 2.18 ± 0.91 vs. RA: 2.35 ± 0.89 ng/mL; Table 5). Glucagon concentrations were elevated 
after the first exercise bout and continued to rise after the second exercise bout in both trials 
(p<0.05; Table 4), suggesting a potential increase in liver contribution to carbohydrate supply via 
gluconeogenesis and glycogenolysis; however there were no differences in glucagon 










































Figure 4. Glucose concentration (A) and AUC (B) from Rest (0 min) to Completion of Exercise  
(60 min). * denotes a significant difference of p<0.05 between trials; different letters denote a 
significance level of p<0.05 between time points (0 vs. 30 vs. 60 min) within a trial. ǂ denotes a 















































Figure 5. Insulin concentration (A) and AUC (B) from Rest (0 min) to Completion of Exercise 
(60 min). * denotes a significant difference of p<0.05 between trials; different letters denote a 
significance level of p<0.05 between time points (0 vs. 30 vs. 60 min) within a trial.  
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Lactate increased from rest during the first exercise bout and continued to increase in the 
second exercise bout of the AR trial. In the RA trial, lactate concentrations increased during the 
resistance exercise portion and then significantly declined during the aerobic exercise portion, 
while still remaining elevated above resting values (p<0.05; Table 4). Overall, lactate 
concentrations were significantly higher at 30 min in the RA trial compared to the AR trial 
whereas at 60 min lactate was greater in the AR trial compared with the RA trial (p<0.05). 
Interestingly, lactate concentrations reached similar values at the end of the aerobic exercise 
bouts for the AR and the RA trials (8.57 ± 2.67 vs. 9.39 ± 2.07 mM, respectively; Table 4).  
Likewise, lactate was similar at the end of the resistance exercise bouts for each trial (AR: 13.45 
± 3.72 vs. RA: 12.42 ± 1.87 mM). 
 
6.3 Energy Expenditure during Exercise 
Oxygen consumption increased significantly from rest for the entire duration of exercise 
in both the AR and RA trials (p<0.05; Table 4). VO2 was elevated following aerobic exercise and 
declined in the subsequent resistance exercise bout (27.73 ± 5.17 to 15.50 ± 1.94 mL/kg/min; 
p<0.05) in the AR trial. The opposite trend was observed in the RA trial (14.81 ± 1.23 after an 
initial bout of resistance exercise to 28.71 ± 4.04 mL/kg/min after the second bout (aerobic) of 
exercise; p<0.05). As expected, VO2 was significantly different between the AR and RA trials at 
30 and 60 min; this may be attributed to the higher VO2 at the completion of the aerobic bout of 
exercise compared to the lower VO2 measured at the completion of the resistance exercise bout 
for each trial. As well, VO2 tended to be higher after a bout of aerobic exercise in the RA trial 
compared to the AR trial (AR: 27.73 ± 5.17, RA: 28.71 ± 4.07 mL/kg/min; Table 5).  
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Similar to VO2, energy expenditure (kcal/kg/day) increased during the first bout of 
aerobic exercise and declined in the second bout of resistance exercise (AR trial), while still 
remaining elevated from rest (p<0.05; Table 4). Energy expenditure was greater than at rest 
during the first bout of resistance exercise in the RA trial, and further increases in energy 
expenditure were observed following the aerobic exercise bout (p<0.05). Total energy 
expenditure for each bout of exercise was calculated. Thirty minutes of aerobic exercise 
expended 256.76 ± 59.31 kcal in the AR trial, which tended to be lower than in the RA trial, 
where 265.82 ± 49.41kcal was expended. Resistance exercise in the AR trial showed a 139.81 ± 
54.18 kcal deficit compared with 122.69 ± 32.90 kcal in the RA trial (p>0.05). Overall, the 
combination of both the aerobic and resistance exercise in the AR and RA trials resulted in a 
total net energy expenditure of 396.57 ± 80.47 kcal (AR trial) and 388.50 ± 55.79 kcal (RA trial), 
with no significant difference in kcal deficit between the two trials (p>0.05).  
 
6.4 Comparison of Substrate Oxidation and Energy Expenditure between Aerobic Exercise Bouts 
and between Resistance Exercise Bouts in the AR and RA Trial 
A comparison of metabolite concentrations at the completion of aerobic exercise between 
trials revealed significantly greater glucose, C-peptide and epinephrine concentrations in the RA 
exercise trial compared to the AR (Table 5). VO2 and energy expenditure tended to be elevated 
after aerobic exercise performed in the RA trial compared to the AR trial (Table 5). No 
significant differences were observed for RER values or for NEFA, glycerol, insulin, glucagon, 
lactate, and norepinephrine concentrations (Table 5).     
When metabolite concentrations were compared between resistance exercise bouts of the 
AR and RA trials, there were significant elevations in insulin and C-peptide concentrations and 
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RER, with concomitant reductions in glycerol concentrations in the resistance bout of the RA 
trial compared to the AR trial (p<0.05; Table 6).     
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1. Data are reported in mean ± SD 




 Trial AR 
Post- Aerobic Exercise Bout 
(30 min) 
Trial RA 
Post- Aerobic Exercise Bout 
(60 min) 
p-value 
RER 0.97 ± 0.02 0.96 ± 0.02 0.64 
VO2 (mL/kg/min) 27.73 ± 5.17 28.71 ± 4.07 0.12 
EE (kcal/kg/min) 0.109 ± 0.02 0.113 ± 0.016 0.11 
NEFA (mM) 0.36 ± 0.14 0.36 ± 0.18 0.89 
Glycerol (mM) 145.77 ± 51.96 175.78 ± 70.64 0.19 
Glucose (mM) 4.50 ± 0.58 4.87 ± 0.39 0.01ǂ 
Insulin (µU/mL) 3.15 ± 2.22 2.93 ± 2.09 0.50 
Glucagon (pg/mL) 149.27 ± 17.48 164.34 ± 44.97 0.35 
C-peptide (ng/mL) 2.18 ± 0.91 2.35 ± 0.89 0.01ǂ 
Lactate (mM) 8.57 ± 2.67 9.39 ± 2.07 0.28 
Epinephrine (pg/mL) 60.41 ± 55.29 73.01 ± 31.58 0.03ǂ 
Norepinephrine (pg/mL) 816.60 ± 277.45 937.30 ± 291.72 0.20 
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1. Data are reported in mean ± SD 
2. ǂ Denotes a significance level of p<0.05 between resistance exercise bout of the AR and RA trials 
 Trial AR 








RER 1.03 ± 0.05 1.07 ± 0.07 0.05ǂ 
VO2 (mL/kg/min) 15.50 ± 1.94 14.81 ± 1.23 0.59 
EE (kcal/kg/min) 0.061 ± 0.008 0.058 ± 0.005 0.55 
NEFA (mM) 0.288 ± 0.084 0.243 ± 0.096 0.91 
Glycerol (mM) 140.68 ± 33.35 96.81 ± 42.11 0.01ǂ 
Glucose (mM) 5.03 ± 0.53 5.18 ± 0.54 0.69 
Insulin (µU/mL) 3.09 ± 2.25 4.71 ± 1.86 0.01ǂ 
Glucagon (pg/mL) 154.28 ± 21.44 141.26 ± 28.41 0.14 
C-peptide (ng/mL) 2.54 ± 1.16 2.96 ± 1.00 0.04ǂ 
Lactate (mM) 13.45 ± 3.72 12.42 ± 1.87 0.34 
Epinephrine (pg/mL) 67.94 ± 31.84 68.84 ± 42.62 0.06 
Norepinephrine (pg/mL) 1037.91 ± 303.07 1175.75 ± 263.84 0.67 
 62 
6.5 Substrate Oxidation during Recovery 
RER, measured immediately post-exercise (60 min), was significantly higher in the AR 
trial compared with the RA trial (0.97 ± 0.07 vs. 0.83 ± 0.07, respectively). There were no 
subsequent differences between trials for the remainder of the recovery. However, RER 
continued to decline significantly (p<0.05) in the AR and RA trials at 75 min and 90 min relative 
to immediately post-exercise (60 min; Table 7), and in the AR trial, RER tended to be further 
reduced after 90 min compared to 75 min (p=0.086). Fat oxidation rates immediately post-
exercise (60 min) were significantly higher for the RA trial compared to the AR trial (0.11 ± 0.04 
vs. 0.00 ± 0.10 g/min). In contrast, carbohydrate oxidation rates were significantly elevated 
immediately post-exercise in the AR trial compared to the RA trial (0.60 ± 0.34 vs. 0.265 ± 0.20 
g/min), which is in line with the RER data. No other significant differences in fat or carbohydrate 
oxidation rates were observed between trials.   
Plasma NEFA concentrations increased 15 min post exercise (75 min) for both trials 
(p<0.05) and subsequently decreased modestly by 90 min whereby it was not significantly 
different from 60 nor 75 min in the recovery period of both trials (Table 7). In addition, the delta 
NEFA concentrations from 60 min to 90 min were not significantly different between trials (AR: 
0.05 ± 0.11 mM vs. RA: 0.07 ± 0.12 mM) In the RA trial, glycerol concentrations were reduced 
15 min post-exercise (75 min) and remained depressed at 30 min post-exercise (90 min) 
compared to immediately post-exercise (60 min, p<0.05; Table 7). In contrast, there were no 
significant changes in post-exercise glycerol concentrations in the AR trial despite that glycerol 
concentrations tended to be reduced at 90 min compared to 60 min (p=0.113) and 75 min 
(p=0.097). Between trials, glycerol concentrations tended to be higher at 60 min in the RA trial 
compared to the AR trial (p=0.112; Table 7).  
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Following the completion of exercise, catecholamine response was reduced significantly 
in both trials after 15 min of recovery (p<0.05) and remained lower after 30 min of recovery 
(Figure 6A&B), similar to baseline concentrations depicted in Figures 3A&B. There were no 
differences in either epinephrine or norepinephrine concentrations at any time point between the 
AR and RA trial (Figure 6A&B). 
There were also no differences in plasma glucose concentrations between trials at any 
time point despite the decrease in glucose concentrations that were observed for both trials after 
15 min recovery (AR: 5.03 ± 0.53 at 60 min to 4.89 ± 0.58 mM at 75 min; RA: 4.87 ± 0.39 at 60 
min to 4.68 ± 0.30 at 75 min, p<0.05; Table 7, Figure 7A). Glucose concentrations remained 
significantly lower at 90 min compared to 60 min (Table 7, Figure 7A).  AUC for glucose was 
significantly lower for the last 15 min of recovery (75 to 90 min) compared to the first 15 min 
immediately post-exercise (60 to 75) in both trials (AR: 38.34 mM*min for 60 to 75 min vs. -
13.13 mM*min for 75 to 90 min, RA: 107.55 mM*min for 60 to 75 min vs. -1.35 mM*min for 
75 to 90 min, p<0.05; Figure 7B). Yet, total glucose AUC during recovery was similar between 
trials. 
Insulin concentrations significantly increased after 15 min recovery in both the AR and 
RA trial and was maintained at 30 min post-exercise (Figure 8A&B, Table 6). In addition, there 
were no differences in insulin concentrations observed between trials. In contrast, C-peptide 
concentrations at 75 min were similar to immediately post-exercise (60 min) and did not 
significantly decline until 90 min (Table 7). Taken together, the insulin and C-peptide results 
suggest that there was not a continual release of insulin into circulation during recovery, but 
rather insulin clearance was reduced after exercise.  
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Contrary to changes during exercise, glucagon concentrations declined during recovery 
such that glucagon concentrations were significantly lower at 75 min and further reduced at 90 
min in both trials (Table 7).   
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Table 7. Metabolite Concentrations at Completion of Exercise and During Recovery 
 Trial AR Trial RA 
Metabolite Immediately Post-












RER 0.97 ± 0.07
a*
 0.72 ± 0.08
b
 0.67 ± 0.03
b
 0.83 ± 0.07
a
 0.71 ± 0.10
b
 0.71 ± 0.07
b
 







































Glycerol (mM) 140.68 ± 33.35 147.38 ± 
69.45 







































































1. Data are reported in mean ± SD 
2. * Denotes a significance level of p<0.05 between trials 




Figure 6. Epinephrine (A) and norepinephrine (B) concentration during recovery. * denotes a 
significant difference of p<0.05 between trials; different letters denote a significance level of 













































Figure 7. Glucose concentration (A) and AUC (B) during recovery. * denotes a significant 
difference of p<0.05 between trials; different letters denote a significance level of p<0.05 

















































Figure 8. Insulin concentration (A) and AUC (B) during recovery. * denotes a significant 
difference of p<0.05 between trials; different letters denote a significance level of p<0.05 
between time points (0 vs. 30 vs. 60 min) within a trial.  
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There was a significant drop in lactate concentrations from 60 to 75 min within each trial 
(p<0.05).  And, there was a further drop in the AR trial by 90 min (Table 7) compared to 75 min, 
while there were no significant differences from 75 to 90 min in the RA trial (Table 7).  Lactate 
concentrations were significantly greater in the AR trial immediately post-exercise and 15 min 
post-exercise (60 min and 75 min, respectively) compared to the RA trial (Table 7). Moreover, 
the delta lactate concentrations from 60 to 90 min were significantly greater for the AR trial  
(-8.94 + 3.91mM) compared to the RA trial (-5.61 + 0.83 mM; p=0.031).  
 
6.6 Energy Expenditure during Recovery 
Oxygen consumption during recovery was similar between trials (Table 7). As expected, 
reductions in VO2 were evident at 75 and 90 min in both trials compared to immediately post-
exercise (p<0.05) and although significance was not achieved, VO2 tended to be lower at 90 min 
compared to 75 min in both trials (p=0.078; Table 6).  
The trend observed for VO2 was paralleled by changes in energy expenditure. Energy 
expenditure was reduced at 75 min compared to values measured immediately post-exercise 
(Table 7). Energy expenditure tended to be reduced from 75 to 90 min for both trials (p=0.091; 
Table 7). In addition, there were no significant differences between the AR and RA trials at any 
time point during recovery. Overall, both trials resulted in a net energy expenditure of 
approximately 40kcal during the 30 min recovery period (AR: 40.34 ± 14.20 and RA: 40.59 ± 
9.75 kcal), which is in comparison to 34.07 ± 5.38 kcal for 30 min rest, measured during the 
initial assessment. 
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6.7 Variation between Aerobic Exercise Bouts Performed on Separate Days 
The values displayed in the Bland-Altman plots for glucose, glycerol, and insulin at 
baseline (0 min) were within 2 SD of the mean difference between the A and AR trials (Figures 9 
to 15 & Table 8). Similarly, Bland-Altman plots for glucose, NEFA, glycerol, epinephrine, 
norepinephrine, and VO2 at completion of the aerobic exercise bout (30 min) were also within 
2SD of the mean difference measured between trials A and AR (Figures 9 to 15 & Table 8). In 
addition, the mean deviation for all trials except VO2, were close to zero, demonstrating minimal 
day-to-day variability within each parameter (Figures 9 to 15 & Table 8). However, the Bland-
Altman plot for NEFA concentration at baseline (0 min) included one participant with values 
above 2 SD. In addition, catecholamine concentration was elevated above 2SD at baseline (0 
min) for one participant in both the epinephrine and norepinephrine Bland-Altman plots. Lastly, 
after completion of exercise (30 min), there was one participant who had RER values that were 
below 2SD of the mean. The participants that had values outside of the 2 SD were different for 
each parameter identified. Despite these deviations from the mean difference, parameters 
measured on different days using the same protocols showed no differences between trials (i.e. 






Table 8. Variability between Two Identical Bouts of Aerobic Exercise Performed on Separate Days 
Note:  
1. Data are reported in mean ± SD 
2. * Denotes a significance level of p<0.05 between trials 
 
 
 0 min 30 min 









Glucose (mM) 4.51 ± 0.35 4.53 ± 0.41 0.895 4.79 ± 0.64 4.50 ± 0.58 0.088 
Insulin (µU/mL) 5.12 ± 2.47 5.25 ± 2.65 0.831 2.54 ± 1.92 3.15 ± 2.22 0.869 
NEFA (mM) 0.391 ± 0.244 0.349 ± 0.150 0.397 0.350 ± 0.191 0.356 ± 0.135 0.397 
Glycerol (mM) 77.49 ± 45.80 80.14 ± 41.78 0.715 142.20 ± 57.23 145.77 ± 51.96 0.715 
Epinephrine 
(pg/mL) 
40.76 ± 50.57 39.57 ± 40.03 0.825 58.37 ± 28.62 60.41 ± 55.49 0.825 
Norepinephrine 
(pg/mL) 
298.96 ± 328.36 278.05 ± 169.27 0.898 830.22 ± 361.04 816.60 ± 277.45 0.898 
VO2 (mL/kg/min)  26.60 ± 4.17 27.73 ± 5.17 0.211 
RER 0.97 ± 0.03 1.27 ± 0.90 0.191 
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Figure 9. Bland-Altman Plot for Glucose Concentration at Baseline (A) and After 
Completion of Aerobic Exercise Bout (B). There were no significant differences 




Figure 10. Bland-Altman Plot for Insulin Concentration at Baseline (A) and After 
Completion of Aerobic Exercise Bout (B). There were no significant differences 




Figure 11. Bland-Altman Plot for NEFA Concentration at Baseline (A) and After 
Completion of Aerobic Exercise Bout (B). There were no significant differences 




Figure 12. Bland-Altman Plot for Glycerol Concentration at Baseline (A) and After 
Completion of Aerobic Exercise Bout (B). There were no significant differences 




Figure 13. Bland-Altman Plot for Epinephrine Concentration at Baseline (A) and After 
Completion of Aerobic Exercise Bout (B). There were no significant differences 




Figure 14.  Bland-Altman Plot for Norepinephrine Concentration at Baseline (A) and 
After Completion of Aerobic Exercise Bout (B). There were no significant differences 




Figure 15. Bland-Altman plot For VO2 (A) and RER (B) After the Completion of an 
Aerobic Exercise Bout (30 min).  
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7.0 Discussion 
This was the first study to investigate the effects of exercise sequence in a 
combined aerobic and resistance exercise session on substrate utilization and energy 
expenditure in recreationally active males. Contrary to our hypothesis that the RA trial 
would result in greater NEFA availability, and thus lipid oxidation, during the aerobic 
exercise bout compared to the AR trial, NEFA availability and lipid oxidation were not 
different for the aerobic portion of each trial. While norepinephrine concentrations were 
elevated to the same extent during both the aerobic and resistance exercise bouts of each 
trial, epinephrine concentrations were significantly higher after a bout of aerobic exercise 
in the RA trial compared to the AR trial. This provides partial support for our hypothesis 
that catecholamine concentrations would be higher during the RA trial compared to the 
AR trial. We also hypothesized that post-exercise lipid oxidation would be augmented, 
and would be accompanied by an increase in energy expenditure, when resistance 
exercise preceded aerobic exercise in comparison to aerobic exercise preceded by a 
resistance exercise bout. Although we did not observe any differences in epinephrine or 
norepinephrine at any time during recovery, glycerol concentrations were elevated 
immediately post-exercise in the RA trial.  An increased mobilization of lipid substrate 
seems likely as relative rates of lipid oxidation were significantly higher immediately 
post-exercise for the RA exercise sequence compared to the AR exercise sequence, but 
there were no changes in energy expenditure. Differences between trials were abolished 
15 minutes into recovery; thus the effect of exercise sequence on post-exercise substrate 
oxidation and energy expenditure may be minimal but requires further investigation.  
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Our final hypothesis was that two identical bouts of moderate intensity aerobic 
exercise, performed on separate days, would elicit the same hormonal response and thus 
produce similar rates of carbohydrate and lipid oxidation for the duration of the aerobic 
exercise bout. In comparing two bouts of aerobic exercise that were performed one week 
apart, we found that there was minimal variability in parameters evaluated for identical 
bouts of moderate-intensity aerobic exercise in healthy, untrained males.  
 
7.1 Substrate Oxidation during Exercise is Not Influenced by Exercise Sequence 
 The anticipated elevation in lipid oxidation in the aerobic bout of the RA trial in 
comparison to the aerobic bout of the AR trial was not observed. In both trials, RER 
values demonstrated that carbohydrate oxidation was the primary source for energy 
provision in the first 30 min of exercise and remained elevated and close to 1.0 regardless 
of the type of exercise. This was in contrast to the findings of Kang et al (2009) where 
RER for aerobic exercise performed subsequent to a bout of resistance exercise was 
approximately 0.87, substantially lower than the RER values reported in our study. In 
addition, RER was significantly lower when aerobic exercise was preceded by high 
intensity resistance exercise compared to aerobic exercise performed without any prior 
exercise (Kang et al, 2009). In the present study, while RER values for the aerobic 
exercise bout during the AR trial were elevated from rest, and in the RA trial, RER values 
declined slightly following resistance exercise, both trials revealed no differences in RER 
values between each aerobic exercise bout. In addition, substrate oxidation rates were 
similar between the aerobic exercise bouts of each trial suggesting that lipid oxidation 
was not influenced by exercise sequence. This discrepancy between Kang et al (2009) 
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and our study results may be due to employment of a different resistance exercise 
protocol: participants in Kang et al (2009) performed 3 sets of 8 repetitions for 6 
exercises at 90% 8-RM, which is equivalent to completing 3 sets of 8 repetitions at 80% 
1-RM for each exercise. Participants in our study performed 3 sets of 8 repetitions for 5 
exercises at 70% predicted 1-RM. Although the male participants in Kang et al (2009) 
had slightly higher BMI values (25.7 ± 2.1 kg/m
2 
compared to 23.9 ± 4.5 kg/m
2 
in our 
study), maximal oxygen consumption was similar (Kang: 35.4 ± 5.6 mL/kg/min vs. 39.52 
± 5.96 mL/kg/min in our study). Since participant characteristics were similar between 
studies, it is possible that a more strenuous resistance exercise protocol, similar to Kang 
et al (2009), would have elicited greater differences in fat oxidation rates between the 
aerobic bouts of the AR and RA trial in our study.  
 NEFA concentrations were not elevated during either AR or RA trial, and in the 
RA trial, NEFA concentrations were significantly reduced after an initial bout of 
resistance exercise. NEFA concentrations remained unchanged from rest after aerobic 
exercise in the AR trial while glycerol concentrations increased, suggesting that NEFA 
was mobilized and released from adipose tissue at the same rate as it was taken up, most 
likely by the exercising skeletal muscle. However, during the aerobic portion of the RA 
trial, there was a simultaneous increase in glycerol and NEFA concentrations, implying 
that while there was increased lipid mobilization, NEFA may not have been taken up by 
skeletal muscle. In context with RER and substrate oxidation values, NEFA were not the 
primary substrate oxidized for energy provision during the aerobic portion of the RA 
trial. According to Goto et al (2007), resistance exercise performed 20 minutes prior to 
aerobic exercise did not increase NEFA concentrations (Goto et al, 2007) and in 
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agreement with our findings, NEFA concentrations were actually depressed prior to the 
initiation of the subsequent bout of aerobic exercise in the RA trial. Interestingly though, 
in Goto et al (2007), fat oxidation was still augmented in the subsequent bout of aerobic 
exercise, despite lower NEFA concentrations, potentially implying that NEFA uptake 
exceeded NEFA mobilization from adipose tissue. This finding was not confirmed in our 
study and Goto et al (2007) suggest that the increased lipid oxidation in the aerobic 
exercise bout could be attributed to elevated catecholamine concentrations. 
In our study, however, only epinephrine —and not norepinephrine— 
concentrations were significantly higher at the end of the aerobic exercise bout of the RA 
trial compared to the AR trial. Epinephrine and norepinephrine increased in the first 30 
min of exercise and remained elevated in both trials above rest until 60 min. While there 
were no further increases in NEFA concentrations compared to rest during the aerobic 
bout of either trial, elevated norepinephrine concentrations –a stimulus for lipolysis in 
adipose tissue (Quish et al, 2005)— and concomitant increases in glycerol concentrations 
support increased NEFA mobilization and subsequent uptake into exercising muscle. 
Glycerol would likely be taken up by the liver as a precursor for gluconeogenesis; 
however since hepatic blood flow is reduced during exercise (Schoemaker et al, 1998), 
glycerol clearance from circulation would likely be slower than NEFA uptake by 
exercising muscles. While elevated insulin concentrations are known to promote 
increased NEFA uptake through CD 36 translocation (Schwenk et al, 2010), the results 
from our study show a drop in insulin concentrations with aerobic exercise. Thus, insulin 
did not likely have a role in the increased NEFA uptake observed for the aerobic portion 
of each trial.    
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However, the low plasma insulin concentrations observed during aerobic exercise 
in both the AR and RA trial were conducive for carbohydrate oxidation. Glucose 
concentrations increased after a bout of resistance exercise in the RA trial to become 
significantly higher during aerobic exercise (compared to the AR trial) and were coupled 
with a significant increase in lactate concentrations compared to rest in both trials. This 
was in agreement with reported RER values to suggest carbohydrate oxidation 
contributed most appreciably to energy provision during the subsequent bout of aerobic 
exercise. Yet, increased plasma glucose concentrations in the RA trial did not result in 
increased glycolysis compared to the AR trial, as Frayn’s estimations (1983) of 
carbohydrate oxidation rates as well as RER values indicate no differences between trials.  
In addition, energy provision was similar between trials. It was expected that 
muscle fatigue from prior resistance exercise would decrease mechanical efficiency 
during the subsequent bout of aerobic exercise in the RA trial compared to the aerobic 
exercise in the AR trial. However, VO2 and energy expenditure were similar for both 
trials suggesting that prior exercise did not influence the mechanical efficiency and 
factors that promote fatigue in the exercising muscle.      
Mechanistically, a rise in AMP: ATP ratio during the resistance exercise bout 
(RA trial), although not measured in this study, would be expected to activate the AMPK 
pathway (Dreyer et al, 2006). The resultant phosphorylation of PFK would increase 
glycogenolysis and glycolysis within the exercising muscle. In addition, elevated Ca
2+ 
and epinephrine concentrations would also activate glycolytic enzymes, promoting 
pyruvate production (Mourtzakis et al, 2006). While increased epinephrine and glucose 
concentrations were observed for the aerobic bout of the RA trial compared to the AR 
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trail, it remains unclear why these increases in hormone and substrate did not stimulate 
increased carbohydrate oxidation. Higher pyruvate concentrations, from increased 
glycolysis, stimulate PDH activity, producing acetyl-CoA as substrate for the TCA cycle.  
Although AMPK activation also removes inhibition of ACC on CPT1 to stimulate 
increased transport of NEFAs into mitochondria, lipid oxidation as estimated by RER 
values, still contributed less to energy provision than carbohydrate oxidation. Perhaps the 
initial depression in plasma NEFA concentrations after resistance exercise in the RA trial 
limited the amount of substrate taken up by skeletal muscle, and thus less NEFA was 
available for CPT1 transport into mitochondria for beta-oxidation. As well, Watt et al 
(2004) found carbohydrate oxidation to be greatest during the first 30 minutes of 
exercise. Since the baseline for initiation of aerobic exercise was altered by prior 
resistance exercise in the RA trial, the increased catecholamine concentrations, reduced 
NEFA concentrations and increased plasma glucose availability should potentially favor 
a greater reliance on carbohydrate oxidation during the aerobic exercise bout. This would 
be in comparison to the aerobic bout of the AR trial, where exercise commenced from 
rest. Thus, skeletal muscle was not primed with energy substrate from a previous exercise 
bout to favor selection of carbohydrates as opposed to lipids for oxidation during the 
aerobic portion of the AR trial.  
In contrast, when resistance exercise was compared between trials, elevated 
insulin and C-peptide concentrations along with higher RER values were observed in the 
RA trial, suggesting a greater reliance on carbohydrate oxidation, and potentially a 
greater activation of the AMPK pathway. In addition, glycerol concentrations were 
maintained similar to rest after a bout of resistance exercise in the RA trial compared to 
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the AR trial where glycerol concentrations were significantly elevated compared to rest 
(as well as compared to a bout of resistance exercise in the RA trial). Since there was a 
drop in NEFA concentrations after resistance exercise in the RA trial (with no changes in 
NEFA concentration in the AR trial), this suggests that insulin could have potentially 
mediated an increase in NEFA uptake during resistance exercise in the RA trial. This 
would likely increase lipid availability for energy provision in the subsequent bout of 
aerobic exercise in the RA trial. However RER was 0.96 which indicates a primary 
reliance on carbohydrate oxidation and thus it remains unclear if resistance exercise 
performed in a RA exercise sequence, has the potential to significantly influence 
substrate oxidation. 
The increased lactate production observed throughout the duration of both trials, 
with greatest production occurring after resistance exercise, was likely the result of an 
increase in pyruvate availability. This could have implications for estimation of 
carbohydrate and lipid oxidation as Kang et al (2009) note that increased acidosis (i.e. 
lactate production) can interfere with the assessment of substrate oxidation from indirect 
calorimetry, such that carbohydrate oxidation may be overestimated while lipid oxidation 
is underestimated. Lactate concentrations measured in our study were higher than 
concentrations measured after resistance exercise in Goto et al (2007), which may 
confound our RER values. Therefore, caution should be used to assess the effect of 
exercise sequence on substrate oxidation at the intensities used in our study.     
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7.2 Substrate oxidation during Recovery is Minimally Influenced by Exercise Sequence 
 This is the first study to our knowledge that evaluates post-exercise substrate 
oxidation when exercise sequence is altered in a combined aerobic and resistance 
exercise session. The findings from this study supported our hypothesis that fat oxidation 
would be increased immediately post-exercise in a resistance-aerobic exercise sequence 
as opposed to an aerobic-resistance exercise sequence. Although RER declined over the 
30 min recovery for both trials, RER was significantly lower in the RA trial immediately 
post-exercise, indicating an increased contribution of lipid oxidation to energy provision. 
According to Frayn’s 1983 estimations of substrate utilization, lipid oxidation was greater 
immediately post-exercise in the RA trial, compared to the AR trial (RA: 0.11 ± 0.04 vs. 
AR: 0.00 ± 0.10 g/min). However, this occurred in absence of changes in energy 
expenditure. NEFA concentrations were elevated immediately after cessation of exercise 
in both trials, while glycerol concentrations were only significantly elevated in the RA 
trial in comparison to the remainder of recovery. It is likely that elevated catecholamine 
concentrations at the cessation of exercise promoted increased TAG breakdown early in 
recovery. Insulin levels, which were depressed immediately after exercise, could have 
potentially had a role in the initial increase in plasma NEFA availability. However, 
insulin concentrations were elevated by 15 min post-exercise and therefore, were not 
likely responsible for the elevated circulating NEFA concentrations during the remainder 
of the recovery period in both trials. The mechanism for continued elevation of NEFA 
concentrations post-exercise, in accord with other studies (Bahr et al, 1991; Kiens and 
Richter, 1998; Goto et al, 2007b; Henderson et al, 2007; Magkos et al, 2007) is still 
unclear. Goto et al (2007) have eluded to growth hormone, which was not measured in 
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this study, as a potential stimulus for lipolysis later in recovery. Glycerol concentrations, 
in contrast, decreased during recovery in the RA trial and were most likely recycled in the 
liver as a precursor for gluconeogenesis. Interestingly, despite the initial differences in 
substrate selection between trials in early recovery (60 min), oxygen consumption and 
energy expenditure during recovery (at 75 and 90 min) were similar for both trials. This 
is in contrast to Drummond et al (2005) who reported increased oxygen consumption, and 
thus energy expenditure for the first 10 minutes immediately following an AR exercise 
sequence in comparison to a RA exercise sequence. However, differences in respiratory 
measures had disappeared by 20 min post exercise (Drummond et al, 2005) and the 
strength of their suggestion that an AR sequence promotes increased energy expenditure 
post-exercise requires further assessment. The differences in post-exercise oxygen 
consumption and energy expenditure observed between our study and Drummond et al 
(2005) could be the result of different exercise programs. In our study, participants cycled 
at 60% VO2 max for 30 min, compared to 70% VO2 max for 25 min in the Drummond et al 
(2005) study. In addition, both studies prescribed 3 sets of 5 exercises at 70% 1RM for 
the resistance exercise bout, however the repetitions and thus the total volume of work in 
our study was lower compared to Drummond et al (2005). Since higher intensity exercise 
elicits greater post-exercise oxygen consumption and energy expenditure (Thorton and 
Potteiger, 2002), our study could potentially have found greater differences in recovery 
between the AR and RA trial if prescribed work intensity had been greater.          
Catecholamine concentration declined over the 30 min recovery, and it is assumed 
that Ca
2+
 concentration was also reduced with the cessation of exercise. The drop in 
concentration for both of these parameters would reduce the activation of the AMPK 
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pathway, which would have important implications on substrate selection: glycogenolytic 
and glycolytic enzyme activity would be reduced. Thus, acetyl-CoA would be derived 
from beta-oxidation. The excess lactate produced during exercise could be taken up and 
oxidized by skeletal muscle, in addition to serving as a precursor for liver 
gluconeogenesis; thus, the decrease in lactate concentrations observed during post-
exercise could support increased glycogen re-synthesis during early recovery. 
Surprisingly, the drop in lactate concentrations during the 30 min recovery, were greater 
for the AR trial compared to the RA trial. Since lactate concentrations were lower in the 
RA trial, the higher delta lactate concentrations for the AR trial versus the RA trial could 
be: 1) a consequence of prior lactate utilization during the aerobic exercise bout of the 
RA trial or 2) increased lactate clearance after resistance exercise in the AR trial.  
 Plasma glucose concentrations were reduced, in concert with depressed RER 
values, during the first 15 min of recovery for both the AR and RA trial. This could be 
explained by greater glucose uptake by skeletal muscle; other studies have suggested that 
glucose uptake remains elevated after exercise for up to 2 hours (Dreyer et al, 2008), 
while carbohydrate oxidation remains depressed to promote glycogen re-synthesis 
(Richter et al, 1989; van Loon et al, 2003). AUC for glucose during recovery was similar 
between trials, but was lower during the last 15 min of the 30 min recovery, indicating 
plasma glucose concentrations were reduced 15 minutes after cessation of exercise. 
Enhanced glucose uptake (presumably by the exercising skeletal muscle) would be 
facilitated by the elevated insulin concentrations during recovery; insulin facilitates 
GLUT 4 translocation as well as CD 36 translocation (Schwenk et al, 2010) and would 
likely provide substrate for glycogen re-synthesis and lipid oxidation respectively. Insulin 
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also activates glycogen synthase (Shepherd et al, 1995); if this enzyme had been 
measured in this study, it would most likely have been elevated post-exercise, confirming 
the switch from carbohydrate oxidation to synthesis after cessation of exercise.   
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7.3 Minimal Variability Between Identical Aerobic Exercise Bouts Performed on 
Separate Days 
One of the secondary aims of this study was to determine the day-to-day 
variability in metabolic and energy-related parameters for moderate-intensity aerobic 
exercise. Bland-Altman plots for primary parameters (i.e. glucose, insulin, NEFA, 
glycerol, epinephrine, norepinephrine, VO2 and RER) showed no significant differences 
between the A and AR trials for fasting (0 min) and after completion of exercise (30 
min). This indicated that the likelihood of day-to-day variability confounding results from 
identical exercise performed on separate days was minimal. However, inter-subject 
variability was large based on the large standard deviation values. Thus variability 
between the A and AR trials was higher relative to the mean difference measured 
between trials for each of the primary parameters. This large variation between trials was 
expected with our heterogeneous group of study participants; had our study sample been 
homogenous (i.e. similar body composition, fasting metabolite concentrations and 
exercise capacities), we would have expected reduced inter-subject variability and in turn 
less day-to-day variability between trials. With respect to the data points that were plotted 
above 2 SD (i.e. Bland-Altman plots for glucose, NEFA, epinephrine and 
norepinephrine), these deviations occurred at baseline and were not observed by the 
completion of exercise.  
 In addition, the trend observed for elevated glucose concentrations at the 
completion of the aerobic exercise bout in the AR trial compared to the A trial (p=0.088) 
should be investigated further with a larger, more homogenous sample size. Since both 
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exercise bouts were performed at the same intensity and same time of day, the same 
hormonal responses should elicit similar changes in glucose metabolism. 
 Overall, the comparison of primary parameters evaluated in trial A and trial AR 
suggested that the repeatability for aerobic exercise of identical volume, intensity and 
duration performed on different days is adequate for attaining results with minimal 
variation.   
 
7.4 Limitations 
Diet prior to each exercise trial was not controlled for in this study. Thus, the 
influence of food prior to the exercise trial is unknown for its effect on substrate 
selection, subsequent oxidation as well as resting energy expenditure. However, 
participants completed an overnight fast prior to each trial, to ensure that fasting 
metabolite values (e.g. glucose, NEFA, epinephrine) were consistent between trials for 
each participant as well as between participants.  
Participants were not instructed to void prior to completing the BIA procedure in 
the initial assessment. While a full bladder has the potential to give a false body fat 
percentage reading, a pilot study was completed to estimate the amount of variance 
between BIA measurements taken pre- and post-voiding. The difference between the two 
body fat percentage values calculated was not significant (Appendix 2), indicating that 
the results obtained in this study were likely an accurate evaluation of body composition 
for each participant.   
Baseline (0 min) measures of VO2 and VCO2 were not collected during the 
exercise trials. Instead of providing a rest period to collect baseline data, participants 
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began cycling shortly after the catheter was inserted. Therefore, resting oxygen 
consumption, energy expenditure and RER values were derived from initial assessment 
data and do not allow for normalization of exercise values to their respective baseline 
values for each trial.  
 Oxygen consumption and carbon dioxide output were measured continuously 
during the aerobic and resistance bouts of each exercise trial. The equipment used 
measured respiratory data breath-by-breath. Since each exercise performed in the 
resistance exercise bout lasted a short duration (approximately 1 to 2 min per set) with 
intermittent rest periods (30 to 60 sec in between each set), it was not practical to stop 
data collection during these breaks in exercise and would likely lead to greater errors 
associated with the measurements. Therefore, VO2 and EE calculated for the resistance 
exercise bout of each trial included both rest and exercise data and we would expect 
measurements of these parameters to likely be higher than the values reported in this 
study, had only VO2 and VCO2 during each exercise been used to calculate EE. However, 
in a real-world setting, resistance exercise is performed with rest periods in between sets 
and thus the values reported in this study, from a practical perspective, are an accurate 
depiction of the changes in VO2 and in turn, EE that occur over the duration of a 
resistance exercise session.  
Energy expenditure was calculated from indirect calorimetry. There were no 
significant differences between aerobic bouts of exercise for the AR and RA trial as well 
during recovery. This suggested that exercise sequence did not affect energy expenditure 
during exercise or post-exercise, however high lactate concentrations could have 
confounded the estimations based on VO2 and VCO2 values in this study (Kang et al, 
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2009). Therefore, further investigation is required to determine if indirect calorimetry 
was either: 1) not sensitive enough to detect changes in energy expenditure between trials 
or 2) there in fact was not a true difference in substrate oxidation patterns when exercise 
sequence was altered.  
Finally, this study was conducted on a small sample size (n=9). There were trends 
observed during exercise and recovery that would likely have reached significance with 
the inclusion of more participants. For example, NEFA concentration after 30 minutes of 
exercise tended to be higher (p=0.056) for the AR trial compared to the RA trial. More 
insight into substrate selection and subsequent oxidation would be gained if trends were 
strengthened to achieve significance.  
 
7.5 Practical Implications and Future Directions 
It was anticipated that the results from this study could be applied to the 
prescription of exercise programs designed to promote weight loss. The results from this 
study suggest that energy expenditure both during exercise and during early recovery (up 
to 30 minutes post-exercise) were not influenced by exercise sequence in a combined 
aerobic and resistance exercise session. However, lipid and carbohydrate oxidation were 
different between the AR and RA trial immediately post-exercise. Future studies should 
prescribe higher intensity exercise and increase the volume of work to determine if 
differences in substrate selection immediately post-exercise would be of a greater 
magnitude and/or sustained for a longer duration in recovery. The influence of a more 
strenuous exercise protocol on energy expenditure could be evaluated for possible 
differences between exercise sequences that we did not observe with the exercise 
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protocol used in this study. Therefore, substrate oxidation and energy expenditure should 
be evaluated for a longer duration (e.g. 24 hours) and at frequent intervals (e.g. every 
hour). Regarding the differences and trends seen in the RA trial compared to the AR trial, 
this would provide greater insight into: 1) how long the increase in plasma NEFA 
concentrations persist post-exercise and 2) whether the increased plasma NEFA 
concentrations observed in the recovery period of the RA trial were taken up by skeletal 
muscle for lipid oxidation  
This study measured blood metabolites and used respiratory data to estimate 
substrate oxidation rates. Future research should measure glycolytic and oxidative 
enzyme activity as well as take muscle biopsies to investigate changes in intramuscular 
glycogen and triacylglyceride content during exercise and recovery.  
8.0 Conclusions 
It can be concluded that contrary to the first hypothesis, a RA exercise sequence 
did not differ with respect to substrate selection and oxidation from an AR exercise 
sequence. Although NEFA concentration was reduced prior to the start of aerobic 
exercise in the RA exercise sequence, it did not appear to influence RER; in addition, 
lipid and carbohydrate oxidation rates remained similar for both the AR and RA trials for 
the duration of exercise. With respect to recovery, lipid oxidation rates were greater 
immediately post-exercise in the RA trial as compared to the AR trial. However, 
differences in substrate oxidation for the remainder of the 30 min recovery were similar 
between trials. Although, there were no significant differences in NEFA or glycerol 
concentration between trials post-exercise, elevations in plasma NEFA and glycerol 
concentration persisted for the duration of recovery in the RA trial, and thus it would be 
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worth investigating if lipid oxidation rates remain similar between trials, or if differences 
between exercise sequences would emerge later in recovery.  
Our hypothesis that catecholamine response to exercise would be heightened with 
a RA exercise sequence was partially confirmed. Epinephrine concentrations were 
significantly higher after aerobic exercise in the RA trial compared to the AR trial, while 
norepinephrine concentrations remained similar between trials. There was, however, a 
tendency for norepinephrine to be elevated after completion of a resistance exercise bout. 
This provides support for the main finding from this study that with only a difference in 
epinephrine, and not norepinephrine, concentrations between the aerobic bouts of each 
trial, catecholamine stimulation of skeletal muscle does not likely affect substrate 
oxidation or utilization when exercise sequence is altered. 
As expected, when two identical bouts of moderate-intensity aerobic exercise 
performed on separate days, metabolite or energy-related parameters were similar 
between trials. This strengthens our study’s ability to compare the crude differences that 
result from alteration of exercise sequence, with minimal day-to-day variation that could 
confound results.  
Overall, exercise sequence did not affect substrate oxidation during exercise and 
very minimally, if at all, during early recovery in healthy, young males. This study 
highlights the importance of exercise, while suggesting that exercise sequence will not 







Abbott, M.J., Edelman, A.M., and Turcotte, L.P. (2009). CaMKK is an upstream signal 
of AMP-activated protein kinase in regulation of substrate metabolism in contracting 
skeletal muscle. Am J Physiol Regul Integr Comp Physiol, 297: R1724-R1732.  
 
Acheson, K.J., Schutz, Y., Bessard, T., Anantharaman, K., Flatt, J-P. and Jéquier. (1988). 
Glycogen storage capacity and de novo lipogenesis during massive carbohydrate 
overfeeding in man. Am J Clin Nutr, 48: 240-247.  
 
Biolo, G., Williams, B.D., Fleming, R.Y.D., and Wolfe, R.R. (1999). Insulin action on 
muscle protein kinetics and amino acid transport during recovery after resistance 
exercise. Diabetes, 48: 949-957.  
 
Bitensky, M.W., Russell, V., and Roberson, W. (1968). Evidence for separate 
epinephrine and glucagon responsive adenyl cyclase systems in rat liver. Biochem 
Biophys Res Comm, 31: 706-712.  
 
Bland, J.M. and Altman, D.G. (1986). Statistical methods for assessing agreement 
between two methods of clinical assessment. Lancet, 1: 307-310.  
 
Bonen, A., Luiken, J.J., Arumugam, Y., Glatz, J.F., and Tandon, N.N. (1999). Acute 
regulation of fatty acid uptake involves the cellular redistribution of fatty acid 
translocase. J Biol Chem, 275: 14501-14508.  
 
Bruce, C.R., Lee, J.S., and Hawley, J.A. (2001). Postexercise muscle glycogen 
resynthesis in obese insulin-resistant Zucker rats. J Appl Physiol, 91: 1512-1519. 
 
Brusq, J-M., Ancellin, N., Grondin, P., Guillard, R., Martin, S., Saintillan, Y., and 
Issandou, M. Inhibition of lipid synthesis through activation of AMP kinase: an 
additional mechanism for the hypolipidemic effects of berberine. J Lipid Res, 47: 1281-
1288.  
 
Cherrington, A.D. and Exton, J.H. (1976). Studies on the role of cAMP-dependent 
protein kinase in the actions of glucagon and catecholamines on liver glycogen 
metabolism. Metabolism, 25: 1351-1354. 
 
DeFronzo, R.A., Ferrannini, E., Sato, Y., Felig, P., and Wahren, J. (1981). Synergistic 
interaction between exercise and insulin on peripheral glucose uptake. J Clin Invest, 68: 
1468-1474. 
 
Dreyer, H.C., Fujita, S., Cadenas, J.G., Chinkes, D.L., Volpi, E., and Rasmussen, B.B. 
(2006). Resistance exercise increases AMPK activity and reduces 4E-BP1 
phosphorylation and protein synthesis in human skeletal muscle. J Physiol¸576: 613-624. 
 
 97 
Dreyer, H.C., Drummond, M.J., Glynn, E.L., Fujita, S., Chinkes, D.L., Volpi, E., and 
Rasmussen, B.B. (2008). Resistance exercise increases human skeletal muscle 
AS160/TBC1D4 phosphorylation in association with enhanced leg glucose uptake during 
postexercise recovery. J Appl Physiol, 105: 1967-1974.  
 
Drummond, M.J., Vehrs, P.R., Schaalje, B., and Parcell, A.C. (2005). Aerobic and 
resistance exercise sequence affects excess postexercise oxygen consumption. J Strength 
Cond Res, 19: 332-337.  
 
Durham, W.J., Miller, S.L., Yeckel, C.W., Chinkes, D.L., Tipton, K.D., Rasmussen, 
B.B., Wolfe, R.R. (2004). Leg glucose and protein metabolism during an acute bout of 
resistance exercise in humans. J Appl Physiol, 97: 1379-1386.  
 
Ehrenborg, E. and Krook, A. (2009). Regulation of skeletal muscle physiology and 
metabolism by peroxisome proliferator-activated receptor δ. Pharmacol Rev, 61: 373-
393.  
 
Exton, J.H. and Park, C.R. (1968). Control of gluconeogenesis in liver: II effects of 
glucagon, catecholamines, and adenosine 3’, 5’-monophosphate on gluconeogenesis in 
the perfused rat liver. J Biol Chem, 243: 4189-4196. 
 
Exton, J.H.(1972). Progress in endocrinology and metabolism: Gluconeogenesis. 
Metabolism, 21: 945-990.  
 
Febbraio, M.A., Lambert, D.L., Starkie, R.L., Proietto, J., and Hargreaves, M. (1998). 
Effect of epinephrine on muscle glycogenolysis during exercise in trained men. J Appl 
Physiol, 84: 465-470.  
 
Finck, B.N. and Kelly, D.P. (2006). PCG-1 coactivators: inducible regulators of energy 
metabolism in health and disease. J Clin Invest, 116: 615-622.  
 
Frayn, K.N. (1983). Calculation of substrate oxidation rates in vivo from gaseous 
exchange. J Appl Physiol, 55: 628-634.  
 
Gaster, M., Handberg, A., Beck-Nielsen, H., and Schrøder, H.D. (2000). Glucose 
transporter expression in human skeletal muscle fibers. Am J Physiol Endocrinol Metab, 
279: E529-E538.  
 
Goto, K., Ishii, N., Sugihara, S., Yoshioka, T., and Takamatsu, K. (2007). Effects of 
resistance exercise on lipolysis during subsequent submaximal exercise. Med Sci Sports 
Exerc, 39: 308-315. 
 
Goto, K., Ishii, N., Mizuno, A., and Takamatsu, K. (2007b). Enhancement of fat 




Griffiths, A.J., Humphreys, S.M., Clark, M.L., Fielding, B.A., and Frayn, K.N. (1994). 
Immediate metabolic availability of dietary fat in combination with carbohydrate. Am J 
Clin Nutr, 59: 53-59.  
 
Gyntelberg, F., Rennie, M.J., Hickson, R.C., and Holloszy, J.O. (1977). Effect of training 
on the response of plasma glucagon to exercise. J Appl Physiol, 43: 302-305.  
 
Hagström-Toft, E., Enoksson, S., Moberg, E., Bolinder, J., and Arner, P. (1998). ß-
adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo. Am J 
Physiol Endocrinol Metab, 275: 909-916. 
 
James, D.E., Piper, R.C., and Slot, J.W. (1994). Insulin stimulation of GLUT-4 
translocation: a model for regulated recycling. Trends Cell Biol, 4: 120-126.  
 
Jiang, G. and Zhang, B.B. (2003). Glucagon and regulation of glucose metabolism. Am J 
Physiol Endocrinol Metab, 284: E671-E678.  
 
Johnson, M.L., Zarins, Z.A., Fattor, J.A., Horning, M.A., Messonnier, L.A., Lehman, 
S.L., and Brooks, G.A. (2010). Twelve weeks of endurance training increases FFA 
mobilization and reesterification in postmenopausal women. J Appl Physiol, Epub ahead 
of print.  
 
Kang, J., Rashti, S.L, Tranchina, C.P., Tatamess, N.A., Faigenbaum, A.D., Hoffman, J.R. 
(2009). Effect of preceding resistance exercise on metabolism during subsequent aerobic 
session. Eur J Appl Physiol, 107: 43-50.  
 
Kahn, B.B., Alquier, T., Carling, D., and Hardie, D.G. (2005). AMP-activated protein 
kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell 
Metab, 1: 15-25.  
 
Kennedy, J.W., Hirshman, M.F., Gervino, E.V., Ocel, J.V., Forse, R.A., Hoenig, S.J., 
Aronson, D., Goodyear, L.J., and Horton, E.S. (1999). Acute exercise induces GLUT4 
translocation in skeletal muscle of normal human subjects and subjects with type 2 
diabetes. Diabetes, 48: 1-6.  
 
Kiens, B., and Richter, E.A. (1998). Utilization of skeletal muscle triacylglycerol during 
post-exercise recovery in humans. Am J Phsyiol Endocrinol Metab, 275: 332-337.  
 
Kiilerich, K., Birk, J.B., Damsgaard, R., Wojtaszewski, J.F. and Pilegaard, H. (2008). 
Regulation of PDH in human arm and leg muscles at rest and during intense exercise. Am 
J Physiol Endocrinol Metab, 294: E36-E42. 
 
Kiilerich, K., Gudmundsson, M., Birk, J.B., Lundby, C., Taudorf, S., Plomgaard, P., 
Saltin, B., Pedersen, P.A., Wojtaszewski, J.F., and Pilegaard, H. (2010). Low muscle 
glycogen and elevated plasma free fatty acid modify but do not prevent exercise-induced 
PDH activation in human skeletal muscle. Diabetes, 59: 26-32.  
 99 
 
Koval, J.A., DeFronzo, R.A., O`Doherty, R.M., Printz, R., Ardehali, H., Granner, D.K., 
and Mandarino, L.J. (1998). Regulation of hexokinase II activity and expression in 
human muscle by moderate exercise. Am J Physiol, 274: E304-E308.  
 
Kraemer, W.J., Noble, B.J., Clark, M.J., and Culver, B.W. (1987). Physiologic responses 
to heavy-resistance exercise with very short rest periods. Int J Sports Med, 8: 247: 252.  
 
Krämer, D.K., Al-Khalili, L., Guigas, B., Leng, Y., Garcia-Roves, P.M., and Krook, A. 
(2007). Role of AMP kinase and PPARδ in the regulation of lipid and glucose 
metabolism in human skeletal muscle. J Biol Chem, 282: 19313-19320.  
 
Kuo, C.C., Fattor, J.A., Henderson, G.C., and Brooks, G.A. (2005). Lipid oxidation in fit 
young adults during post-exercise recovery. J Appl Physiol, 99: 349-356.  
 
Kurth-Kraczek, E.J., Hirshman, M.F., Goodyear, L.J., and Winder, W.W. (1999). 5’ 
AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle. 
Diabetes, 48: 1667-1671.  
 
Lavoie, C., Ducros, F., Bourque, J., Langelier, H., and Chiasson, J.L. (1997). Glucose 
metabolism during exercise in man: the role of insulin and glucagon in the regulation of 
hepatic glucose production and gluconeogenesis. Can J Physiol Pharmacol, 75: 26-35.  
 
Lee-Young, R.S., Griffee, S.R., Lynes, S.E., Bracy, D.P., Ayala, J.E., McGuinness, O.P., 
and Wasserman, D.H. (2009). Skeletal muscle AMP-activated protein kinase is essential 
for the metabolic response to exercise in vivo. J Biol Chem, 284: 23925-23934.  
 
Lizcano, J.M. and Alessi, D.R. (2002). The insulin signaling pathway. Curr Biol, 12: 
R236-R238.  
 
Magkos, F., Patterson, B.W., Mohammed, B.S., and Mittendorfer, B. (2007). A single 1-h 
bout of evening exercise increases basal FFA flux without affecting VLDL-triglyceride 
and VLDL-apolipoprotein B-100 kinetics in untrained lean men. Am J Physiol 
Endocrinol Metab, 292: E1568-E1574. 
 
Matarese, L.E. (1997). Indirect calorimetry: technical aspects. J Am Diet Assoc, 97: 
S154-S160.  
 
McGarry, J.D. and Foster, D.W. (1980). Effects of exogenous fatty acid concentration on 
glucagon-induced changes in hepatic fatty acid metabolism. Diabetes, 29: 236-240.  
 
Melby, C., Scholl, C., Edwards, G., and Bullough, R. (1993). Effect of acute resistance 
exercise on postexercise energy expenditure and resting metabolic rate. J Appl Physiol, 
75: 1847-1853.  
 
 100 
Michiels, C. (2004). Physiological and pathological responses to hypoxia. Am J Pathol, 
164: 1875-1882.  
 
Mourtzakis, M., Saltin, B., Graham, T., and Pilegaard, H. (2006). Carbohydrate 
metabolism during prolonged exercise and recovery: interactions between pyruvate 
dehydrogenase, fatty acids and amino acids. J Appl Physiol, 100: 1822-1830.  
 
Mourtzakis, M., Graham, T.E., González-Alonso, J., and Saltin, B. (2008). Glutamate 
availability is important in intramuscular amino acid metabolism and TCA cycle 
intermediates but does not affect peak oxidative metabolism. J Appl Physiol, 105: 547-
554.  
 
Näveri, H., Kuoppasalmi, K., and Härkönen, M. (1985). Plasma glucagon and 
catecholamines during exhaustive short-term exercise. Eur J Appl Physiol Occup Physiol, 
53: 308-311.  
 
Ojuka, E.O., Jones, T.E., Nolte, L.A., Chen, M., Wamhoff, B.R., Sturek, M., and 
Holloszy, J.O. (2002). Regulation of GLUT4 biogenesis in muscle: evidence for 
involvement of AMPK and Ca(2+). Am J Physiol Endocrinol Metab, 282: E1008-E1013.  
 
Ojuka, E.O., Nolte, L.A., and Holloszy, J.O. (2000). Increased expression of GLUT-4 
and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro. J Appl Physiol, 
88: 1072-1075.  
 
Ormsbee, M.J., Thyfault, J.P., Johnson, E.A., Kraus, R.M., Choi, M.D., and Hickner, 
R.C. (2007). Fat metabolism and acute resistance exercise in trained men. J Appl Physiol, 
102: 1767-1772.  
 
Ormsbee, M.J., Choi, M.D., Medlin, J.K., Geyer, G.H., Trantham, L.H., Dubis, G.S., and 
Hickner, R.C. (2009). Regulation of fat metabolism during resistance exercise in 
sedentary lean and obese men. J Appl Physiol, 106: 1529-1537.  
 
Perry, C.G., Heigenhauser, G.J., Bonen, A., and Spriet, L.L. (2008). High-intensity 
aerobic interval training increases fat and carbohydrate metabolic capacities in human 
skeletal muscle. Appl Physiol Nutr Metab, 33: 1112-1123.  
 
Petersen, K.F., Price, T.B., and Bergeron, R. (2004). Regulation of net hepatic 
glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes. J Clin 
Endocrinol Metab, 89: 4656-4664. 
 
Petitt, D.S., Arngrimsson, S.A., and Cureton, K.J. (2003). Effect of resistance exercise on 
postprandial lipemia. J Appl Phsyiol, 94: 694-700.  
 
Quisth, V., Enoksson, S., Blaak, E., Hagström-Toft, E., Arner, P., and Bolinder, J. 
(2005). Major differences in noradrenaline action on lipolysis and blood flow rates in 
skeletal muscle and adipose tissue in vivo. Diabetologia, 48: 946-953.  
 101 
 
Raney, M.A. and Turcotte, L.P. (2006). Regulation of contraction-induced FA uptake and 
oxidation by AMPK and ERK1/2 is intensity dependent in rodent muscle. Am J Physiol 
Endocrinol Metab, 291: E1220-E1227. 
 
Richter, E.A., Mikines, K.J., Glabo, H., and Kiens, B. (1989). Effect of exercise on 
insulin action in human skeletal muscle. J Appl Physiol, 66: 876-885.  
 
Robergs, R.A., Pearson, D.R., Costill, D.L., Fink, W.J., Pascoe, D.D., Benedict, M.A., 
Lambert, C.P., and Zachweija, J.J. (1991). Muscle glycogenolysis during differing 
intensities of weight-resistance exercise. J Appl Physiol, 70: 1700-1706.  
 
Romijn, J.A., Klein, S., Coyle, E.F., Sidossis, S., and Wolfe, R.R. (1993). Strenuous 
endurance training increases lipolysis and triglyceride-fatty acid cycling at rest. J Appl 
Physiol, 75: 108-113.  
 
Romijn, J.A., Coyle, E.F., Sidossis, L.S., Gastaldelli, A., Horowitz, J.F., Endert, E., and 
Wolfe, R.R. (1993b). Regulation of endogenous fat and carbohydrate metabolism in 
relation to exercise intensity and duration. Am J Physiol, 265: E380-E391. 
 
Romijn, J.A., Coyle, E.F., Sidossis, L.S., Zhang, X.J. and Wolfe, R.R. (1995). 
Relationship between fatty acid delivery and fatty acid oxidation during strenuous 
exercise. J Appl Physiol, 79: 1939-1945.  
 
Romijn, J.A., Coyle, E.F., Sidossis, L.S., Rosenblatt, J., and Wolfe, R.R. (2000). 
Substrate metabolism during different exercise intensities in endurance-trained women. J 
Appl Physiol, 88: 1707-1714.  
 
Roy, B.D. and Tarnopolsky, M.A. (1998). Influence of differing macronutrient intakes on 
muscle glycogen re-synthesis after resistance exercise. J Appl Physiol, 84: 890-896. 
 
Savard, R., Despres, J.P., Marcotte, M., Theriault, G., Tremblay, A., and Bouchard, C. 
(1987). Acute effects of endurance exercise on human adipose tissue metabolism. 
Metabolism, 36: 480-485.  
 
Schewnk, R.W., Dirkx, E., Coumans, W.A., Bonen, A., Klip, A., Glatz, J.F., and Luiken, 
J.J. (2010). Requirement for distinct vesicle-associated membrane proteins in insulin- and 
AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD 36 in 
cultured cardiomyocytes. Diabetologia, Epub ahead of print.  
 
Schoemaker, R.C., Burggraaf, J., and Cohen, A.F. (1998). Assessment of hepatic blood 
flow using continuous infusion of high clearance drugs. Br J Clin Pharmacol, 45: 463-
469. 
 
Shearer, J., and Graham, T.E. (2002). New perspectives on the storage and organization 
of muscle glycogen. Can J Appl Phsyiol, 27: 179-203. 
 102 
 
Shepherd, P.R., Navé, B.T., and Siddle, K. (1995). Insulin simulation of glycogen 
synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 
3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 
ribosomal protein-S6 kinase. Biochem J, 305: 25-28. 
 
Singhal, A., Trilk, J.L., Jenkins, N.T., Bigelman, K.A., and Cureton, K.J. (2009). Effect 
of intensity of resistance exercise on postprandial lipemia. J Appl Physiol, 106: 823-829.  
 
Smart, J.B. and Pritchard, G.G. (1982). Control of pyruvate kinase activity during 
glycolysis and gluconeogenesis in propionibacterium shermanii. J Gen Microbiol, 128: 
167-176.  
 
Stallknecht, B., Lorentsen, J., Enevoldsen, L.H., Bülow., J., Biering-SØrensen, F., Glabo, 
H., and Kjaer, M. (2001). Role of sympathoadrenergic system in adipose tissue 
metabolism during exercise in humans. J Physio, 536: 283-294.  
 
Stanley, W.C. and Connett, R.J. (1991). Regulation of muscle carbohydrate metabolism 
during exercise. FASEB J, 5: 2155-2159.  
 
Steinberg, G.R., Macaulay, S.L., Febbraio, M.A., and Kemp, B.E. (2006). AMP-activated 
protein kinase—the fat controller of the energy railroad. Can J Physiol Pharmacol, 84: 
655-665.  
 
Stephens, F.B., Norton, L., Jewell, K., Chokkalingam, K., Parr, T., and Tsintzas, K. 
(2010). Basal and insulin-stimulated pyruvate dehydrogenase complex activation, 
glycogen synthesis and metabolic gene expression in human skeletal muscle the day after 
a single bout of exercise. Exp Physiol,95: 808-818.  
 
Stich, V., de Glisezinski, I., Berlan, M., Bulow, J., Galitzky, J., Harant, I., Suljkovicova, 
H., Lafontan, M., Rivière, D., and Crampes, F. (2000). Adipose tissue lipolysis is 
increased during a repeated bout of aerobic exercise. J Appl Physiol, 88: 1277-1283.  
 
Sugden, M.C., Caton, P.W., and Holness, M.J. (2010). PPAR control: it’s SIRTainly as 
easy as PGC. J Endocrinol, 204: 93-104.  
 
Thorton, M.K. and Potteiger, J.A. (2002). Effects of resistance exercise bouts of different 
intensities but equal work on EPOC. Med Sci Sports Exerc, 34: 715-722. 
 
van Loon, L. J., Greenhaff, P.L., Constantin-Teodosiu, D., Saris, W.H., and 
Wagenmakers, A.J. (2001). The effects of increasing exercise intensity on muscle fuel 
utilization in humans. J Physiol, 536: 295-304.  
 
van Loon,  L.J.C., Koopman, R., Stegen, J.H.C.H., Wagenmakers, A.J.M., Keizer, H.A., 
and Saris, W.H.M. (2003). Intramyocellular lipids form an important substrate source 
 103 
during moderate intensity exercise in endurance-trained males in a fasted state. J Physiol, 
553: 611-625.  
 
Votruba, S.B., Atkinson, R.L., Hirvonen, M.D., and Schoeller, D.A. (2002). Prior 
exercise increases subsequent utilization of dietary fat. Med Sci Sports Exerc, 34: 1757-
1765.  
 
Wahren, J., Felig, P., Ahlborg, G., and Jorfeldt, L. (1971). Glucose metabolism during 
leg exercise in man. J Clin Invest, 50: 2715-2725. 
 
Wang, Y.X., Zhang, C.L., Yu, R.T., Cho, H.K., Nelson, M.C., Bayuga-Ocampo, C.R., 
Ham, J., Kang, H., and Evans, R.M. (2004). Regulation of muscle fiber type and running 
endurance by PPARdelta. PLoS Biol, 2: E294. 
 
Wang, Z., Iwasaki, Y., Zhao, L.F., Nishiyama, M., Taguchi, T., Tsugita, M., 
Kambayashi, M., Hashimoto, K., and Terada, Y. (2009). Hormonal regulation of 
glycolytic enzyme gene and pyruvate dehydrogenase kinase/phosphatase gene 
transcription. Endoc J, 56: 1019-1030.  
 
Wasserman, K., Hansen, J.E., Sue, D.Y., Stringer, W.W., and Whipp, B.J. (2005). Gas 
exchange kinetics. Principles of exercise testing and interpretation including 
pathophysiology and clinical applications 4
th
 Ed., 55-56.  
 
Watt, M.J., Heigenhauser, G.J., Stellingwerff, T., Hargreaves, M., and Spriet, L.L. 
(2002). Carbohydrate ingestion reduces skeletal muscle acetylcarnitine availability but 
has no effect on substrate phsophorylation at the onset of exercise in man. J Phsyiol, 544: 
949-956. 
 
Watt, M.J., Heigenhauser, G.J., LeBlanc, P.J., Inglis, J.G., Spriet, L.L., and Peters, S.J. 
(2004). Rapid upregulation of pyruvate dehydrogenase kinase activity in human skeletal 
muscle during prolonged exercise. J Appl Physiol, 97: 1261-1267.  
 
WHO. (1995). Physical status: The use and interpretation of anthropometry. Report of a 
WHO expert consultation. WHO Technical Report Series Number 854, Geneva: World 
Health Organization.  
 
Wøjtaszewski, J.F.P., Jørgensen, S.B., Frøsig, C., MacDonald, C., Birk, J.B., and Richter, 





Appendix One. Incremental Exercise Test Protocol 
 
UNIVERSITY OF WATERLOO OFFICE OF RESEARCH ETHICS STANDARD 
OPERATING PROCEDURES UWHSOP212- Protocol for Conducting an Exercise Test 
to Measure Oxygen Consumption (VO2) on a Cycle Ergometer  
  
Purpose: This SOP describes the procedures for the setup, calibration and execution of 
an exercise test to measure oxygen consumption (VO2) on a cycle ergometer.   
  
Responsibility: Faculty researchers or supervisors, undergraduate and graduate students  
  
1.0 Preparation of participants  
  
1.1 Each potential participant will be asked if he/she has any conditions that would affect 
his/her ability to participate in exercise, and will be asked to complete the Health Status 
Form. Persons with known cardiovascular disease or any other condition that would 
compromise his/her ability to safely participate in exercise are advised that they cannot 
participate in the exercise test. According to the American College of Sports Medicine 
(ACSM) guidelines, any participant will not be permitted to start the exercise test if blood 
pressure is measured as equal to or above 144/90 mmHg. Likewise, the exercise test will 
be concluded if blood pressure rises above 250/110 mmHg at any point during the test. A 
medical health questionnaire, appropriate for the particular participant population, should 
also be administered at the start of the testing session to identify any co-morbidities the 
participant may have as well as determine the participant’s physical activity level.   
  
1.2 Potential participants will be asked to wear a loose fitting t-shirt, comfortable 
pants/shorts and running shoes on the day of the test. Participants will also be asked to 
refrain from consumption of alcohol or engaging in heavy exercise 24 hours prior to the 
test. It is recommended that no food be consumed 2 hours prior to exercise, as this may 
affect the participant’s ability to optimally perform the test and the participant may 
develop nausea during the test if consuming food close to the time of testing.   
  
1.3 Potential participants are also advised to avoid participation in the exercise test if 
he/she is allergic to rubbing alcohol, as it is used to prepare the skin for electrode 
placement to measure heart rate.    
  
2.0 Calibration of equipment  
  
2.1 The Vmax system (Sensormedics Corp.) is turned on and both the flow and gas 
exchange equipment are calibrated according to the Vmax software system requirements. 
Calibration values must be saved in order for the Vmax system to allow the 
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commencement of an exercise test.   
  
3.0 Exercise test procedures  
  
3.1  Participant information (height, weight and birth date) is collected and entered into 
the Vmax system; this information is required and used by the Vmax system to calculate 
accurate respiratory values. An exercise test is then selected from the Vmax system 
software (selection depends on the respiratory variables desired for collection).  
  
3.2 Three electrodes are placed on the participant’s chest, using the CM5 placement 
(center of the manubrium and on the 5th ribs) and the participant is connected to the 
electrocardiogram (ECG) machine as per UWSOP-209 to provide a continuous 
measurement of heart rate at rest and during exercise. Blood pressure will also be 
monitored at rest and every two minutes during exercise using a manual 
sphygmomanometer and stethoscope.   
  
3.3 The participant will be fitted with a Hans-Rudolph facemask or mouthpiece and nose 
clip, depending on apparatus preference, availability or study protocol used within the 
laboratory. The facemask is fitted snugly onto the participant’s nose first and then pulled 
down and cupped under the chin. It is secured to the face with a mesh-netting that clips 
onto each side of the facemask. As the facemask needs to be air-tight, the participant will 
be asked to cover the tube that allows for air intake with his/her hand (~2 seconds) and 
will be asked to forcefully exhale to assure that there are no air leaks. If air leaks exist, 
the mask will be adjusted or tightened and the air-leak test will be repeated. The 
facemask and flow sensor are cleaned and sterilized between participants; see section 4.0 
below.  
  
The mouthpiece has a bite block component which fits inside the participant’s mouth, 
like a snorkel mouthpiece. The nose clips are then placed on the participant’s nose to 
occlude airflow into the nostrils. The mouthpiece and nose clip are cleaned and sterilized 
between participants; see section 4.0 below.  
  
3.4  The cycle ergometer seat height is adjusted to be level with the participant’s hip 
height (i.e. when the participant sits on the cycle ergometer, there will be a slight bend in 
the knees) and handlebars are adjusted to ensure maximal comfort.   
  
3.5 Exercise measures  
  
Incremental exercise  
The incremental exercise test takes 8 to 12 minutes to complete and will include a 2-3 
minute resting period, in which the participant will sit on the cycle ergometer while 
cardiovascular, respiratory and rating of perceived exertion values are collected. 
Immediately following the rest stage, the participant will begin his/her first stage, which 
will serve as a warm up. The work rate will be between ~10 to 50 Watts, depending on 
the participant’s physical activity level (which is determined in the medical health 
questionnaire, completed at the same time as the consent form).   
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Pedaling resistance is increased at the beginning of each new stage according to the  
participant’s rating of perceived exertion level from the previous stage, and is highly 
specific to each participant. Typically, work rates are increased by ~10 to 25 Watts in 
untrained individuals and by ~50 Watts in trained participants or those that participate 
regularly in physical activity.  
  
Each stage is 1-3 minutes long and the participant will complete 2-3 stages for a 
submaximal exercise test or between 4 to 6 stages for a maximal test. For a sub-maximal 
test, the target for each stage is longer (i.e. ~3 minutes) to ensure the participant has 
reached steady state before increasing the pedaling intensity; the accuracy and 
consistency of the values collected at each of these stages is critical, as this data will be 
used to predict maximal oxygen consumption (VO2 max). If a maximal test is being 
completed, a two-minute stage duration should provide sufficient time for attaining 
steady state values before increasing the work rate (this data will not be involved in any 
prediction equations); VO2 max will be determined from the last stage.   
  
Heart rate  
Heart rate is measured continuously at rest and during the exercise test. Values are  
automatically transferred and recorded from the ECG machine onto the Vmax system.   
  
Blood pressure  
Blood pressure values are collected at rest and every two minutes during the exercise test.   
  
Respiratory values  
Gas exchange values are measured using the facemask or the mouthpiece and nose clips 
and are automatically recorded on the Vmax system.   
  
Rating of perceived exertion  
Participants are asked to subjectively assess the relative effort levels imposed on him/her 
by the exercise, using the Borg scale (6-20). These values are collected at rest and every 
two minutes during the exercise test and will be used to determine the increase in 
pedaling resistance for the following exercise stage.   
  
Revolutions per minute  
The revolutions per minute (RPM) as digitally displayed on the cycle ergometer should 
be between 50 to 100 rpm for the entire test.   
  
3.6 The exercise test is terminated for the following reasons:   
• Pre-determined endpoint (ex. 85% of age-predicted maximum heart rate); as occurs 
with  
a sub-maximal test  
• Participant is fatigued and requests to stop the test  
• RPM cannot be maintained above 50   
• ECG abnormalities  
• Chest pain, shortness of breath, dizziness, light-headedness  
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• Blood pressure fails to rise or drops > 10 mmHg below baseline with increased work 
rate, SBP is > 250 mmHg or DBP > 115 mmHg  
  
3.7 Immediately after the exercise test is stopped, the pedaling intensity is reduced to a 
light intensity (ex. 25 Watts), for a five minute cool-down period. The mouthpiece or 
facemask is removed from the participant’s mouth or face, respectively and heart rate and 
blood pressure will continue to be monitored according to the same protocols used during 
the test.   
  
3.8 Heart rate and blood pressure should decrease, although they will most likely be 
higher than pre-exercise levels as the body continues to recover from the exercise. If the 
participant demonstrates any signs of discomfort (ex. Light-headedness), the participant 
will be assisted off of the cycle ergometer and onto the floor, with feet elevated, to 
alleviate the abnormal feelings induced by the exercise. In the event of a medical 
emergency, call 911 immediately.     
  
3.9 The exercise test pulmonary results are averaged over 10, 20, 30 or 60 seconds and 
tabulated on the computer screen. The results can be saved to the Vmax system or printed 
off for analysis.   
  
4.0 Equipment cleaning and sterilization   
  
4.1 The mouthpiece and noseclips or facemask and flow sensor are washed in warm 
water that has a small amount (approximately 1 teaspoon) of Terga-Zyme added to the 
mixture. Equipment is then rinsed and placed in Cidex, a disinfectant, for 10 minutes. 
The mouthpiece and noseclips or facemask are submerged in Cidex. The flow sensor 
should be placed in a separate, shallower container of Cidex, such that the adaptor piece 
which connects the flow sensor to the Vmax system is not exposed to the disinfectant (as 
it can cause damage to this part of the apparatus).   
  
After 10 minutes in Cidex, the equipment is rinsed in warm water and allowed to air dry 
for  
future use. Prior to the next user, the facemask is wiped with 0.5% hydrogen peroxide to 
rid of any Cidex residue.  
  
4.2 The two samples lines are disconnected from the Vmax system and hung to air dry 
before the next use.   
  
4.3 The cycle ergometer seat and handles as well as the blood pressure cuff are wiped 
down with 3% hydrogen peroxide solution.   
  
5.0 Discussion of risks  
  
5.1 The risks of doing incremental exercise to a participant’s functional limit are very 
similar to the risks of doing heavy voluntary exercise. There is a very slight chance that 
an apparently healthy individual will have a cardiovascular complication that has not 
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been previously detected during normal medical examinations. There is no way to predict 
this potential complication.  
  
5.2 In a very small group of individuals, a skin rash may occur due to the adhesive on the  
electrodes used to measure heart rate. The rash is expected to disappear within a few 
days. Participants are advised to avoid scratching the rash and to keep the area clean.    
   
On occasion a slightly pink to reddish mark may occur at the site of the electrodes when  
removed. While this generally dissipates within minutes, in some people, it may take up 
to two days.   
  
Rubbing alcohol is used to clean the skin before electrode placement to measure heart 
rate. Therefore, participants are advised not to participate in the exercise test if he/she is 
allergic to rubbing alcohol.  
  
5.3 The mouthpiece and noseclips or facemask and flow sensor are sterilized after each  
participant’s use to eliminate any risk of spread of infection.   
  




Appendix Two. Pilot Bioelectrical Impedance Analysis (BIA) Data  
 
In this thesis study, participants did not void prior to BIA assessment. This pilot study 
was to evaluate the differences in body fat percentage measurements pre- and post-
voiding to estimate error associated with not including this procedure in the original 
testing protocol.  
 
Protocol 
Participants were asked to consume 500 mL of water 30 to 60 min and this was followed 
by an initial  BIA assessment (pre-voiding). Following the pre-voiding measurement, 
participants were asked to void and a second  BIA measurement was collected (post-
voiding).  
 
 Body Fat Percentage (%) Difference in Pre – Post 
Measurement (%) Participant Pre-voiding Post-voiding 
01 26.98 26.83 0.15 
02 25.38 25.51 -0.13 
03 30.27 30.10 0.17 
04 17.44 17.52 -0.08 
05 24.46 24.54 -0.08 
Average 24.90 24.90 0.01 
SD 4.72 4.63 0.12 





















Appendix Three. Mean Co-efficient of Variance (COV) for Metabolite Measures 
 
Metabolite COV ± SE (%) Range of COVs 
Glucose 1.77 ± 3.51 0.00 to 36.47 
NEFA 4.98 ± 2.73 0.90 to 15.70 
Glycerol 1.03 ± 1.04 0.00 to 6.97 
Lactate 1.25 ± 1.11 0.00 to 5.09 
Insulin 20.64 ± 22.55 0.00 to 124.10 
Glucagon 10.25 ± 12.60 0.08 to 67.61 
C-peptide 9.49 ± 7.45 0.34 to 40.12 
Cholesterol 1.47 ± 1.19 0.00 to 3.19 
HDL 4.66 ± 2.72 2.00 to 9.90 
Triacylglyerol  2.21 ± 1.09 0.58 to 3.66 





























Appendix Four. Sample Size and Power Calculation Results 
 
 
Variable Exercise Post-Exercise Recovery 
Sample size to achieve 
80% statistical power 
Statistical power (%) for 
study sample size (n=9) 
Sample size to achieve 
80% statistical power 
Statistical power (%)  for 
study sample size (n=9) 
Glucose 113 7.68 92 5.00 
NEFA 63 5.00 24 17.80 
Glycerol 38 5.00 132 5.00 
RER 8 86.00 20 65.6 
Notes:  
1. Values reported in the table represent power achieved when differences are compared between the AR and RA trial.  
2. Values at 60 min and at 90 min were compared between trials to determine sample size to reach 80% statistical power during 
exercise and post-exercise recovery, respectively 
